


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:49:35Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406319" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406319</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>ejpt</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Psychotraumatol</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Psychotraumatol</journal-id><journal-id journal-id-type="pmc-domain-id">1804</journal-id><journal-id journal-id-type="pmc-domain">ejpt</journal-id><journal-title-group><journal-title>European Journal of Psychotraumatology</journal-title></journal-title-group><issn pub-type="epub">2000-8066</issn><publisher><publisher-name>Taylor &amp; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406319</article-id><article-id pub-id-type="pmcid-ver">PMC12406319.1</article-id><article-id pub-id-type="pmcaid">12406319</article-id><article-id pub-id-type="pmcaiid">12406319</article-id><article-id pub-id-type="pmid">40891466</article-id><article-id pub-id-type="doi">10.1080/20008066.2025.2545734</article-id><article-id pub-id-type="publisher-id">2545734</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Effectiveness of phase-oriented treatment for trauma-related dissociative disorders: a systematic review</article-title><trans-title-group xml:lang="es"><trans-title>Efectividad del tratamiento orientado a fases para los trastornos disociativos relacionados con el trauma: una revisi&#243;n sistem&#225;tica</trans-title></trans-title-group><alt-title alt-title-type="right-running-head">EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY</alt-title><alt-title alt-title-type="left-running-head">T. A. GRIFFITHS ET AL.</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0007-3673-0661</contrib-id><name name-style="western"><surname>Griffiths</surname><given-names initials="TA">Thomas A.</given-names></name><xref rid="AF1" ref-type="aff">a</xref><xref rid="AF2" ref-type="aff">b</xref><xref rid="an1" ref-type="author-notes"/><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0862-3515</contrib-id><name name-style="western"><surname>Dimitrova</surname><given-names initials="LI">Lora I.</given-names></name><xref rid="AF3" ref-type="aff">c</xref><xref rid="an1" ref-type="author-notes"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Linington</surname><given-names initials="M">Mark</given-names></name><xref rid="AF3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Terhune</surname><given-names initials="DB">Devin B.</given-names></name><xref rid="AF4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Reinders</surname><given-names initials="AATS">Antje A. T. S.</given-names></name><xref rid="AF5" ref-type="aff">e</xref></contrib><aff id="AF1"><label>a</label><institution>Institute of Psychiatry, Psychology &amp; Neuroscience, King&#8217;s College London</institution>, <city>London</city>, <country>UK</country></aff><aff id="AF2"><label>b</label><institution>Maudsley NHS Foundation Trust</institution>, <city>London</city>, <country>UK</country></aff><aff id="AF3"><label>c</label><institution>Clinic for Dissociative Studies</institution>, <city>London</city>, <country>UK</country></aff><aff id="AF4"><label>d</label>Department of Psychology, <institution>Institute of Psychiatry, Psychology &amp; Neuroscience, King&#8217;s College London</institution>, <city>London</city>, <country>UK</country></aff><aff id="AF5"><label>e</label>Department of Psychological Medicine, <institution>Institute of Psychiatry, Psychology &amp; Neuroscience, King&#8217;s College London</institution>, <city>London</city>, <country>UK</country></aff></contrib-group><author-notes><corresp id="cor1"><label>CONTACT</label> Thomas A. Griffiths <email xlink:href="thomas.a.griffiths@kcl.ac.uk">thomas.a.griffiths@kcl.ac.uk</email><institution>Institute of Psychiatry, Psychology &amp; Neuroscience, King&#8217;s College London</institution>, <addr-line>Addiction Sciences Building, 4 Windsor Walk</addr-line>, <city>London</city><postal-code>SE5 8AF</postal-code>, <country>UK</country></corresp><fn id="an1"><label>*</label><p>Joint first author.</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2025</year></pub-date><volume>16</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">478730</issue-id><elocation-id seq="217">2545734</elocation-id><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event><event event-type="received"><date><day>3</day><month>3</month><year>2025</year></date></event><event event-type="revised"><date><day>11</day><month>7</month><year>2025</year></date></event><event event-type="accepted"><date><day>4</day><month>8</month><year>2025</year></date></event><event event-type="tagger"><event-desc>Nova techset</event-desc><date><day>11</day><month>8</month><year>2025</year></date></event><event event-type="build-issue-online"><event-desc>Converted to JATS 1.2 by Nova Techset</event-desc><date><day>11</day><month>8</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="ZEPT_16_2545734.pdf"/><self-uri content-type="pdf" xlink:href="ZEPT_16_2545734.pdf"/><abstract><title>ABSTRACT</title><p><bold>Background:</bold> Dissociative disorders (DDs) are a group of mental health conditions characterised by disconnection from thoughts, feelings, memories, or sense of identity. It is believed that DDs, particularly dissociative identity disorder (DID) result from severe and chronic childhood trauma. Guidance from the International Society for the Study of Trauma &amp; Dissociation (ISSTD) recommends trauma-informed phase-oriented treatment (PoT) to treat DDs. To date, there has been no systematic evaluation of treatment effectiveness of PoT in DDs.</p><p><bold>Objective:</bold> This review aimed to systematically assess published studies and evaluate the evidence and effectiveness of PoT for DDs relative to other treatments.</p><p><bold>Method:</bold> The search included four databases from 1980&#8211;2025 and reference lists of core papers. Studies were included if (1) participants have a primary diagnosis of DID or other specified dissociative disorder (OSDD), (2) it examined PoT and/or other treatments in these populations, and (3) it used at least one outcome measure pre- and post-treatment. Study quality was assessed using the Effective Public Health Practice Project (EPHPP) tool.</p><p><bold>Results:</bold> 6088 articles were screened and 19 articles met the inclusion criteria. All treatment types were associated with improvements in symptoms of dissociation, general mental health symptoms, psychopathology, and general functioning. When compared to one another, each treatment type has its strengths depending on the outcome of interest.</p><p><bold>Conclusions:</bold> This review demonstrates an emerging evidence base for using psychological interventions to treat DDs. High-powered controlled trials are needed to build upon these results to inform clinical practice.</p></abstract><abstract abstract-type="plain-language-summary"><title>HIGHLIGHTS</title><p>
<list list-type="bullet"><list-item><p>Dissociative disorders such as dissociative identity disorder are considered to be severe forms of PTSD. Guidelines for treating these disorders are still in their infancy. The recommended treatment is trauma-based phase-oriented psychotherapy, but there has been no evaluation of its effectiveness.</p></list-item><list-item><p>This systematic review summarised and evaluated 19 studies that examined the effectiveness of phase-oriented treatment for dissociative disorders as compared to other treatments.</p></list-item><list-item><p>All types of treatment, including phase-oriented treatment, individual psychotherapy, and group therapy improved symptoms in dissociative disorders.</p></list-item><list-item><p>High powered controlled trials are needed to inform clinical practice.</p></list-item></list>
</p></abstract><trans-abstract xml:lang="es"><p><bold>Antecedentes:</bold> Los trastornos disociativos (TD) son un grupo de trastornos de salud mental que se caracterizan por la desconexi&#243;n de los pensamientos, sentimientos, recuerdos o el sentido de identidad. Se cree que los TD, en particular el trastorno de identidad disociativo (TID), son consecuencia de un trauma infantil grave y cr&#243;nico. La Sociedad Internacional para el Estudio del Trauma y la Disociaci&#243;n (ISSTD) recomienda un tratamiento orientado a fases (PoT por sus siglas en ingl&#233;s) basado en el trauma para tratar los TD. Hasta la fecha, no se ha realizado una evaluaci&#243;n sistem&#225;tica de la eficacia del PoT en los TD.</p><p><bold>Objetivo:</bold> Esta revisi&#243;n tuvo como objetivo evaluar sistem&#225;ticamente los estudios publicados y evaluar la evidencia y la efectividad del PoT para los DD en relaci&#243;n con otros tratamientos.</p><p><bold>M&#233;todo:</bold> La b&#250;squeda incluy&#243; cuatro bases de datos de 1980 a 2025 y listas de referencias de art&#237;culos clave. Se incluyeron los estudios si (1) los participantes ten&#237;an un diagn&#243;stico principal de TID u otro trastorno disociativo especificado (TDSE), (2) examinaban el PoT y/u otros tratamientos en estas poblaciones, y (3) utilizaban al menos una medida de resultados antes y despu&#233;s del tratamiento. La calidad de los estudios se evalu&#243; mediante la herramienta del Proyecto de Pr&#225;cticas Efectivas en Salud P&#250;blica (EPHPP por sus siglas en ingles).</p><p><bold>Resultados:</bold> Se analizaron 6.088 art&#237;culos y 19 cumplieron los criterios de inclusi&#243;n. Todos los tipos de tratamiento se asociaron con mejoras en los s&#237;ntomas de disociaci&#243;n, los s&#237;ntomas generales de salud mental, la psicopatolog&#237;a y el funcionamiento general. Al compararlos entre s&#237;, cada tipo de tratamiento presenta ventajas seg&#250;n el resultado de inter&#233;s.</p><p><bold>Conclusiones:</bold> Esta revisi&#243;n demuestra una base de evidencia emergente para el uso de intervenciones psicol&#243;gicas en el tratamiento de los trastornos disociativos. Se necesitan ensayos controlados de alta potencia para fundamentar estos resultados y orientar la pr&#225;ctica cl&#237;nica.</p></trans-abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>Dissociation</kwd><kwd>trauma</kwd><kwd>dissociative disorder</kwd><kwd>dissociative identity disorder</kwd><kwd>other specified dissociative disorder</kwd><kwd>treatment</kwd><kwd>interventions</kwd><kwd>psychotherapy</kwd><kwd>phase-oriented treatment</kwd></kwd-group><kwd-group kwd-group-type="author" xml:lang="es"><title>PALABRAS CLAVE</title><kwd>Disociaci&#243;n</kwd><kwd>trauma</kwd><kwd>trastorno disociativo</kwd><kwd>trastorno de identidad disociativo</kwd><kwd>otro trastorno disociativo especificado</kwd><kwd>tratamiento</kwd><kwd>intervenciones</kwd><kwd>psicoterapia</kwd><kwd>tratamiento orientado a fases</kwd></kwd-group><counts><fig-count count="3"/><table-count count="4"/><equation-count count="0"/><ref-count count="47"/><page-count count="15"/><word-count count="7715"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" disp-level="1" id="S001"><label>1.</label><title>Introduction</title><sec disp-level="2" id="S001-S2001"><label>1.1.</label><title>Dissociation and dissociative disorders</title><p>Dissociation is the experience of disconnect from thoughts, feelings, memories, or sense of identity (American Psychiatric Association [APA], <xref rid="CIT0001" ref-type="bibr">2013</xref>; Loewenstein et al., <xref rid="CIT0027" ref-type="bibr">2024</xref>). When dissociation is severe and impairs a person&#8217;s ability to function normally it may be a symptom of a dissociative disorder (DD). There are several types of DDs and the most severe is dissociative identity disorder (DID; Reinders &amp; Veltman, <xref rid="CIT0041" ref-type="bibr">2021</xref>). Research highlights a robust correlation between DDs and early childhood trauma (Chalavi et al., <xref rid="CIT0009" ref-type="bibr">2015</xref>; Rafiq et al., <xref rid="CIT0038" ref-type="bibr">2018</xref>). The Trauma model posits that DID is a severe post-traumatic stress disorder (PTSD) resulting from early/repeated childhood abuse (Dalenberg et al., <xref rid="CIT0014" ref-type="bibr">2012</xref>; Raison &amp; Andrea, <xref rid="CIT0039" ref-type="bibr">2023</xref>). In this view, dissociation is a subconscious defence mechanism wherein the individual experiences disrupted integration of normal psychological functions in response to trauma, causing dissociation to protect against traumatic stress (Dimitrova et al., <xref rid="CIT0015" ref-type="bibr">2024</xref>). This coping mechanism persists beyond the offset of trauma and causes high degrees of psychiatric and psychosocial impairment. The opposite model is referred to as Fantasy model (Dalenberg et al., <xref rid="CIT0014" ref-type="bibr">2012</xref>) which states the dissociation is due to fantasy proneness and symptoms can be iatrogenically induced during treatment (Lilienfeld, <xref rid="CIT0026" ref-type="bibr">2007</xref>).</p></sec><sec disp-level="2" id="S001-S2002"><label>1.2.</label><title>Treatments for dissociative disorders</title><p>Treatment guidelines for DDs recommended by the International Society for the Study of Trauma &amp; Dissociation (ISSTD, <xref rid="CIT0019" ref-type="bibr">2011</xref>) include individually-focused psychotherapy as the primary treatment, with psychiatric medication as a helpful adjunct. Psychotherapy for DDs involves working through the trauma that triggers dissociation to improve understanding and coping with symptoms (Loewenstein et al., <xref rid="CIT0027" ref-type="bibr">2024</xref>). The recommended treatment modality is psychodynamic psychotherapy but can integrate other modalities too e.g. cognitive behavioural therapy (CBT), hypnosis, and group therapies. Alike treatments for other trauma-related disorders, treatment duration for DDs is generally long-term.</p></sec><sec disp-level="2" id="S001-S2003"><label>1.3.</label><title>Phase-oriented treatment for dissociative disorders</title><p>ISSTD (<xref rid="CIT0019" ref-type="bibr">2011</xref>) recommends that psychotherapy for DDs utilises a phase-oriented treatment (PoT) approach. This involves three phases: (1) stabilisation and symptom reduction; (2) treating trauma memories, and (3) identity reintegration and rehabilitation. PoT is based on structural dissociation theory (Steele et al., <xref rid="CIT0050" ref-type="bibr">2005</xref>); it suggests that individuals with trauma-related disorders and/or those experiencing pathological dissociation suffer from a division of identity into different parts, each with its own autobiographical underpinnings. The aim of PoT is to raise the integrative capacity of these identity states. Although PoT is the recommended treatment approach for DDs there are no published systematic reviews investigating its effectiveness. The <italic toggle="yes">Treatment of Patients with Dissociative Disorders</italic> (TOP DD) study (Brand et al., <xref rid="CIT0006" ref-type="bibr">2009</xref>) is currently the largest body of research investigating the most effective interventions for DDs. It analysed treatment outcomes of 280 DID/dissociative disorder not otherwise specified (DDNOS) patients over 30 months. They found that treatment was associated with decreased dissociative and PTSD symptomatology, depression, suicide attempts, self-harm, drug use, and hospitalisations, alongside improved social/emotional functioning.</p></sec><sec disp-level="2" id="S001-S2004"><label>1.4.</label><title>Aims</title><p>Preliminary evidence points to the therapeutic efficacy of PoT for DDs (Subramanyam et al., <xref rid="CIT0051" ref-type="bibr">2020</xref>), but there has been no systematic evaluation of its effectiveness. Accordingly, the present systematic review aims to examine the effectiveness of PoT, as well as other treatments for DDs, on the four domains most affected in DDs: (1) dissociation, (2) general mental health symptoms, (3) psychopathology, and (4) general functioning in domains of cognitive, social, and occupational functioning.</p></sec></sec><sec sec-type="methods" disp-level="1" id="S002"><label>2.</label><title>Method</title><p>This systematic review follows Cochrane guidance on conducting review and Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines (Page et al., <xref rid="CIT0034" ref-type="bibr">2021</xref>). The PICOS framework was used to determine eligibility criteria for study inclusion (Methley et al., <xref rid="CIT0030" ref-type="bibr">2014</xref>). This review protocol was pre-registered with PROSPERO (2021; CRD42021253478) with minor modifications made in February 2024.</p><sec disp-level="2" id="S002-S2001"><label>2.1.</label><title>Inclusion and exclusion criteria</title><p>Studies were included if they met the following criteria: (1) the sample included adult human participants; (2) published from 1980 onwards, the year that MPD was first mentioned in the DSM-III; (3) participants received a DSM primary diagnosis of DID, MPD, or other specified dissociative disorder (OSDD)/DDNOS; (4) examined the effectiveness of PoT for DDs, or compared PoT to other treatments, and (5) used at least one clear, measurable, and validated outcome from questionnaires, interviews, and/or tasks measuring symptoms, emotion regulation, global functioning, higher adaptive capacities, and quality of life pre- and post-treatment. No restrictions were placed on treatment type or length. Studies were excluded if they met the following criteria: (1) not published in the English language, and (2) non-peer-reviewed pieces of work.</p></sec><sec disp-level="2" id="S002-S2002"><label>2.2.</label><title>Search strategy</title><p>A systematic search using four databases (PubMed, OVID, PsycINFO, Web of Science) was undertaken in January 2025. Grey literature was not included. The search terms used were based on a previous systematic review by one of the authors (Roydeva &amp; Reinders, <xref rid="CIT0045" ref-type="bibr">2021</xref>), adding only keywords related to PoT. The search terms were: &#8216;dissociative disorder*&#8217; OR &#8216;dissociative identity disorder*&#8217; OR &#8216;DID disorder*&#8217; OR &#8216;DID personalit*&#8217; OR &#8216;DID psychiatr*&#8217; OR &#8216;DID mental*&#8217; OR &#8216;DID dissociat*&#8217; OR &#8216;DID identit*&#8217; OR &#8216;multiple personality disorder*&#8217; OR &#8216;MPD&#8217; OR &#8216;dissociative disorder not otherwise specified&#8217; OR &#8216;DDNOS&#8217; OR &#8216;other specified dissociative disorder&#8217; OR &#8216;OSDD&#8217; AND &#8216;treatment*&#8217; OR &#8216;phase-oriented&#8217; OR &#8216;outcome&#8217; OR &#8216;therap*&#8217; OR &#8216;longitudinal&#8217;. Databases were searched using title, abstracts, and keywords, and references were imported into Endnote. Reference lists of core papers were assessed for eligible literature.</p></sec><sec disp-level="2" id="S002-S2003"><label>2.3.</label><title>Selection process</title><p>Searches from all databases were exported into Endnote 20 for duplicate removal by TG. The remaining references were then uploaded to Rayyan (<ext-link xlink:href="http://www.rayyan.ai" ext-link-type="uri">www.rayyan.ai</ext-link>). Two reviewers (TG and LD) independently screened all titles and abstracts for inclusion according to the inclusion/exclusion criteria. Next, both coders independently screened all full-text studies for final inclusion. Authors were contacted to request relevant study data if not reported in-text. For both stages of screening, agreement between reviewers was calculated using percentages and Cohen&#8217;s Kappa (McHugh, <xref rid="CIT0029" ref-type="bibr">2012</xref>). Disagreements were resolved through discussion or with another member of the team.</p></sec><sec disp-level="2" id="S002-S2004"><label>2.4.</label><title>Data extraction</title><p>Data extraction was undertaken using a prespecified spreadsheet created for the review. The following information was extracted from included studies: author(s); publication year; journal; study design; participant number; diagnosis; treatment interventions delivered; outcome measures; and study findings. Data extraction was independently conducted by the two reviewers with discrepancies resolved through discussion or consulting another member of the review team.</p></sec><sec disp-level="2" id="S002-S2005"><label>2.5.</label><title>Quality assessment</title><p>Study quality and risk of bias was assessed using the Effective Public Health Practice Project (EPHPP; <xref rid="F0002" ref-type="fig">Figure 2</xref>; Armijo-Olivo et al., <xref rid="CIT0002" ref-type="bibr">2012</xref>). All papers were assessed for quality by both reviewers; disagreements were resolved through discussion or consulting another member of the team.</p></sec></sec><sec sec-type="results" disp-level="1" id="S003"><label>3.</label><title>Results</title><sec disp-level="2" id="S003-S2001"><label>3.1.</label><title>Study selection</title><p>A PRISMA flow diagram is shown in <xref rid="F0001" ref-type="fig">Figure 1</xref>.
<fig position="float" id="F0001" orientation="portrait"><label>Figure 1.</label><caption><p>PRISMA flow diagram of steps of the systematic review (Moher et al., <xref rid="CIT0031" ref-type="bibr">2009</xref>).</p><p>Notes: 6088 articles were retrieved from the four databases, as well as 11 articles from the reference lists of core papers (see Supplementary materials). From a total of 6099 articles, 2521 duplicates were removed. 3578 articles were screened by title and abstract against inclusion/exclusion criteria. 3521 references were excluded due to failure to meet inclusion criteria, yielding 57 papers for full-text screening. 38 articles were excluded at this stage, leaving 19 articles which met eligibility criteria and included in the review. Two studies (Kellett, <xref rid="CIT0022" ref-type="bibr">2005</xref>; Ross &amp; Haley, <xref rid="CIT0044" ref-type="bibr">2004</xref>) were included based on indirectly meeting inclusion criteria; they used DID/OSDD diagnostic instruments that were based on DSM criteria but did not specifically state that participants met DSM criteria for DID.</p></caption><alt-text>Flow diagram showing records identified, screened, excluded with reasons, and included in the review, following PRISMA guidelines.</alt-text><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="ZEPT_A_2545734_F0001_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="ZEPT_A_2545734_F0001_PB.jpg"/></alternatives></fig></p></sec><sec disp-level="2" id="S003-S2002"><label>3.2.</label><title>Study and sample characteristics</title><p>Study and sample characteristics are shown in <xref rid="T0001" ref-type="table">Table 1</xref>. Studies were published between 1980&#8211;2022; 84% (<italic toggle="yes">k</italic>&#8201;=&#8201;16) were published after 2000. Most studies (79%) took place in the U.S.A. (<italic toggle="yes">k</italic>&#8201;=&#8201;15). All studies recruited participants from clinical settings. Concerning study design, six (32%) were uncontrolled single case studies and one was a single case experimental design. Eight (42%) were uncontrolled case series with sample sizes ranging from 3&#8211;72 participants. Two were cross-sectional studies; one was a cohort study, and one study was a randomised controlled trial (RCT).
<table-wrap position="float" id="T0001" orientation="landscape"><label>Table 1.</label><caption><p>Study and sample characteristics of studies (<italic toggle="yes">k</italic>&#8201;=&#8201;19).</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">Study</th><th align="center" colspan="1" rowspan="1">Location</th><th align="center" colspan="1" rowspan="1">Study design</th><th align="center" colspan="1" rowspan="1">Setting</th><th align="center" colspan="1" rowspan="1">Sample<break/>(<italic toggle="yes">n</italic>)</th><th align="center" colspan="1" rowspan="1">Gender<break/>(% M/F)</th><th align="center" colspan="1" rowspan="1">Ethnicity</th><th align="center" colspan="1" rowspan="1">Age<break/>(<italic toggle="yes">M</italic> in years)</th><th align="center" colspan="1" rowspan="1">Diagnosis (comorbid diagnoses)</th><th align="center" colspan="1" rowspan="1">Diagnostic criteria</th><th align="center" colspan="1" rowspan="1">Medication</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Choe and Kluft (<xref rid="CIT0011" ref-type="bibr">1995</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Case series</td><td align="left" colspan="1" rowspan="1">Inpatient</td><td align="char" char="." colspan="1" rowspan="1">21</td><td align="left" colspan="1" rowspan="1">100% F</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="char" char="." colspan="1" rowspan="1">33.2</td><td align="left" colspan="1" rowspan="1">DID</td><td align="left" colspan="1" rowspan="1">DDIS</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Boyd (<xref rid="CIT0005" ref-type="bibr">1997</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Case study</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">100% F</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="char" char="." colspan="1" rowspan="1">23</td><td align="left" colspan="1" rowspan="1">DID</td><td align="left" colspan="1" rowspan="1">SCID-D</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Manchester et al. (<xref rid="CIT0028" ref-type="bibr">1998</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Case series</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">11</td><td align="left" colspan="1" rowspan="1">100% F</td><td align="left" colspan="1" rowspan="1">100% White</td><td align="char" char="." colspan="1" rowspan="1">41.1</td><td align="left" colspan="1" rowspan="1">DID</td><td align="left" colspan="1" rowspan="1">DSM-III</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Coons and Bowman (<xref rid="CIT0013" ref-type="bibr">2001</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Case series</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">12</td><td align="left" colspan="1" rowspan="1">100% F</td><td align="left" colspan="1" rowspan="1">100% White</td><td align="char" char="." colspan="1" rowspan="1">39.6</td><td align="left" colspan="1" rowspan="1">DID</td><td align="left" colspan="1" rowspan="1">DSM-III</td><td align="left" colspan="1" rowspan="1">Unspecified anti-depressant, unspecified anti-anxiety, unspecified anti-antipsychotic</td></tr><tr><td align="left" colspan="1" rowspan="1">Gold et al. (<xref rid="CIT0017" ref-type="bibr">2001</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Case series</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">100% F</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="char" char="." colspan="1" rowspan="1">50</td><td align="left" colspan="1" rowspan="1">DID (2 PTSD, MDD, &amp; PD; 1 BPD)</td><td align="left" colspan="1" rowspan="1">DSM-IV</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Sar et al. (<xref rid="CIT0046" ref-type="bibr">2002</xref>)</td><td align="left" colspan="1" rowspan="1">Turkey</td><td align="left" colspan="1" rowspan="1">Case study</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">100% F</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="char" char="." colspan="1" rowspan="1">18</td><td align="left" colspan="1" rowspan="1">DID</td><td align="left" colspan="1" rowspan="1">SCID-D</td><td align="left" colspan="1" rowspan="1">Paroxetine and Trazodone</td></tr><tr><td align="left" colspan="1" rowspan="1">Ross and Haley (<xref rid="CIT0044" ref-type="bibr">2004</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Case series</td><td align="left" colspan="1" rowspan="1">Inpatient</td><td align="char" char="." colspan="1" rowspan="1">46</td><td align="left" colspan="1" rowspan="1">96% F</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="char" char="." colspan="1" rowspan="1">36.1</td><td align="left" colspan="1" rowspan="1">DID</td><td align="left" colspan="1" rowspan="1">DDIS</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Humphreys et al. (<xref rid="CIT0018" ref-type="bibr">2005</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Case study</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">100% F</td><td align="left" colspan="1" rowspan="1">100% White</td><td align="char" char="." colspan="1" rowspan="1">18</td><td align="left" colspan="1" rowspan="1">DID</td><td align="left" colspan="1" rowspan="1">DSM-IV</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Kellett (<xref rid="CIT0022" ref-type="bibr">2005</xref>)</td><td align="left" colspan="1" rowspan="1">UK</td><td align="left" colspan="1" rowspan="1">SCED</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">100% F</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="center" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">DID</td><td align="left" colspan="1" rowspan="1">NIMH RDoC</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Gantt and Tinnin (<xref rid="CIT0016" ref-type="bibr">2007</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Case series</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">50</td><td align="left" colspan="1" rowspan="1">77% F</td><td align="left" colspan="1" rowspan="1">98% White;<break/>2% not specified</td><td align="char" char="." colspan="1" rowspan="1">38</td><td align="left" colspan="1" rowspan="1">37 DDNOS;<break/>13 DID</td><td align="left" colspan="1" rowspan="1">DSM-IV</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Brand et al. (<xref rid="CIT0006" ref-type="bibr">2009</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Cross-sectional</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">237</td><td align="left" colspan="1" rowspan="1">94% F</td><td align="left" colspan="1" rowspan="1">89% White;<break/>2% African American;<break/>2% Hispanic;<break/>2% Asian;<break/>5% Other</td><td align="char" char="." colspan="1" rowspan="1">43.7</td><td align="left" colspan="1" rowspan="1">DID and DDNOS<sup>a</sup></td><td align="center" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Unspecified anti-depressant, unspecified anti-anxiety</td></tr><tr><td align="left" colspan="1" rowspan="1">Myrick et al. (<xref rid="CIT0032" ref-type="bibr">2012</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Case series</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">29</td><td align="left" colspan="1" rowspan="1">91% F</td><td align="left" colspan="1" rowspan="1">86% White;<break/>14% not specified</td><td align="char" char="." colspan="1" rowspan="1">25.7</td><td align="left" colspan="1" rowspan="1">23 DID;<break/>6 DDNOS</td><td align="left" colspan="1" rowspan="1">DSM-IV</td><td align="left" colspan="1" rowspan="1">Unspecified anti-depressant, unspecified anti-anxiety</td></tr><tr><td align="left" colspan="1" rowspan="1">Jepsen et al. (<xref rid="CIT0020" ref-type="bibr">2014</xref>)</td><td align="left" colspan="1" rowspan="1">Norway</td><td align="left" colspan="1" rowspan="1">Case series</td><td align="left" colspan="1" rowspan="1">Inpatient</td><td align="char" char="." colspan="1" rowspan="1">23</td><td align="left" colspan="1" rowspan="1">93% F</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="char" char="." colspan="1" rowspan="1">39.5</td><td align="left" colspan="1" rowspan="1">19 DDNOS;<break/>4 DID</td><td align="left" colspan="1" rowspan="1">SCID-D</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Brand and Loewenstein (<xref rid="CIT0007" ref-type="bibr">2014</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Cross-sectional</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">237</td><td align="left" colspan="1" rowspan="1">94% F</td><td align="left" colspan="1" rowspan="1">89% White;<break/>2% African American;<break/>2% Hispanic;<break/>2% Asian;<break/>5% Other</td><td align="char" char="." colspan="1" rowspan="1">43.7</td><td align="left" colspan="1" rowspan="1">DID &amp; DDNOS</td><td align="center" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Unspecified anti-depressant, unspecified anti-anxiety</td></tr><tr><td align="left" colspan="1" rowspan="1">Schiepek et al. (<xref rid="CIT0048" ref-type="bibr">2016</xref>)</td><td align="left" colspan="1" rowspan="1">Austria</td><td align="left" colspan="1" rowspan="1">Case study</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">100% F</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="center" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">DID (BPD)</td><td align="left" colspan="1" rowspan="1">DSM-IV and SCID-D</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Pollock et al. (<xref rid="CIT0036" ref-type="bibr">2017</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Case study</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">100% M</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="char" char="." colspan="1" rowspan="1">58</td><td align="left" colspan="1" rowspan="1">DID (MDD, SUD)</td><td align="left" colspan="1" rowspan="1">DSM-IV</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Brand et al. (<xref rid="CIT1001" ref-type="bibr">2019</xref>)</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Cohort study</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">111</td><td align="left" colspan="1" rowspan="1">88% F</td><td align="left" colspan="1" rowspan="1">86% White<break/>4% Hispanic<break/>2% Asian<break/>2% Black<break/>6% Other</td><td align="char" char="." colspan="1" rowspan="1">43</td><td align="left" colspan="1" rowspan="1">DID &amp; DDNOS</td><td align="left" colspan="1" rowspan="1">DSM-IV and DSM-V</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Barbieri et al. (<xref rid="CIT0004" ref-type="bibr">2022</xref>)</td><td align="left" colspan="1" rowspan="1">Italy</td><td align="left" colspan="1" rowspan="1">Case study</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">100% M</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="char" char="." colspan="1" rowspan="1">38</td><td align="left" colspan="1" rowspan="1">OSDD (PTSD &amp; BPD)</td><td align="left" colspan="1" rowspan="1">SCID-V, DDIS</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Baekkelund et al. (<xref rid="CIT0003" ref-type="bibr">2022</xref>)</td><td align="left" colspan="1" rowspan="1">Norway</td><td align="left" colspan="1" rowspan="1">RCT</td><td align="left" colspan="1" rowspan="1">Outpatient</td><td align="char" char="." colspan="1" rowspan="1">59</td><td align="left" colspan="1" rowspan="1">93% F</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="char" char="." colspan="1" rowspan="1">35.2</td><td align="left" colspan="1" rowspan="1">DID &amp; OSDD</td><td align="left" colspan="1" rowspan="1">SCID-D</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>Notes: &#8211;&#8201;=&#8201;not reported. <sup>a</sup>&#8201;=&#8201;specific number of each diagnosis was not reported. BPD&#8201;=&#8201;borderline personality disorder; DDIS&#8201;=&#8201;dissociative disorders interview schedule; DDNOS&#8201;=&#8201;dissociative disorder not otherwise specified; DID&#8201;=&#8201;dissociative identity disorder; DSM&#8201;=&#8201;Diagnostic and Statistical Manual of Mental Disorders; MDD&#8201;=&#8201;major depressive disorder; NIMH RDoC&#8201;=&#8201;National Institute of Mental Health Research Domain Criteria; OSDD&#8201;=&#8201;other specified dissociative disorder; PD&#8201;=&#8201;panic disorder; PTSD&#8201;=&#8201;post-traumatic stress disorder; RCT&#8201;=&#8201;randomised controlled trial; SCED&#8201;=&#8201;single case experimental design; SCID-D&#8201;=&#8201;structured clinical interview for dissociative disorders; SUD&#8201;=&#8201;substance use disorder. Table summarising 19 included studies with columns for study, location, design, setting, sample size, gender, ethnicity, age, diagnosis and comorbidities, diagnostic criteria, and medication details.</p></fn></table-wrap-foot></table-wrap></p><p>619 adult participants were included, accounting for the fact that two studies analysed different outcomes from the same TOP DD study sample. Sample sizes ranged from 1&#8211;237 (median&#8201;=&#8201;17). Most participants were female (91%) and ages ranged from 18&#8211;72 years. Ten studies did not report ethnicity; among those that did, most participants were White. All participants had primary diagnoses of either DID or OSDD. Three studies included participants with comorbid PTSD, three with depression, two with borderline personality disorder, and one each with panic disorder or substance use disorder. Most studies used diagnostic criteria from the DSM, including DSM-III (<italic toggle="yes">k</italic>&#8201;=&#8201;2), DSM-IV (<italic toggle="yes">k</italic>&#8201;=&#8201;7), DSM-IV SCID-D (<italic toggle="yes">k</italic>&#8201;=&#8201;5), and DSM-V (<italic toggle="yes">k</italic>&#8201;=&#8201;2). Three studies used the Dissociative Disorders Interview Schedule (DDIS) and one used the National Institute of Mental Health Research Domain Criteria (NIMH RDoC) for DID. 26% (<italic toggle="yes">k</italic>&#8201;=&#8201;5) of studies included participants that were prescribed psychotropic medication, the most common being anti-depressants. 14 studies did not record or report medication use.</p></sec><sec disp-level="2" id="S003-S2003"><label>3.3.</label><title>Quality assessment</title><p>EPHPP ratings are presented in <xref rid="F0002" ref-type="fig">Figure 2</xref>.
<fig position="float" id="F0002" orientation="portrait"><label>Figure 2.</label><caption><p>Quality assessment ratings of included studies using the EPHPP tool (<italic toggle="yes">k</italic>&#8201;=&#8201;19).</p><p>Notes: Study quality and risk of bias was assessed using the Effective Public Health Practice Project (EPHPP; Armijo-Olivo et al., <xref rid="CIT0002" ref-type="bibr">2012</xref>). This tool was selected as it provides a standardised means to assess quality of quantitative studies and develop recommendations from study findings. The EPHPP tool comprises six sections to be rated by reviewers: selection bias, design, confounders, blinding, data collection methods, withdrawal, and dropouts. The tool provides overall ratings of &#8216;strong&#8217;, &#8216;moderate&#8217;, or &#8216;weak&#8217; in each domain. A global rating is determined for each study based on the number of sections rated as weak. EPHPP has good content and construct validity and adequate inter-rater reliability (Armijo-Olivo et al., <xref rid="CIT0002" ref-type="bibr">2012</xref>). Concerning global rating, 58% (<italic toggle="yes">k</italic>&#8201;=&#8201;11) of studies were rated as weak, 32% (<italic toggle="yes">k</italic>&#8201;=&#8201;6) as moderate, and 11% (<italic toggle="yes">k</italic>&#8201;=&#8201;2) as strong. The domain &#8216;blinding&#8217; produced the greatest risk of bias with 84% of studies being rated as weak. 58% of studies were rated as weak on the &#8216;confounders&#8217; domain. EPHPP domains &#8216;study design&#8217; and &#8216;selection bias&#8217; received mostly moderate ratings. Concerning study design, most studies were rated moderate for their use of single case studies/series without a comparison/control group; only Baekkelund et al. (<xref rid="CIT0003" ref-type="bibr">2022</xref>) was rated as strong for its use of an RCT. Concerning selection bias, 47% of studies were rated as strong with the remaining 53% rated as moderate. Data collection methods were an area of relative strength with all studies being rated as strong. All studies used valid/reliable outcome measures. Given the varying quality of studies and more than half receiving weak global ratings, initial conclusions can be drawn but findings need to be repeated with more methodologically robust designs.</p></caption><alt-text>Grid displaying quality ratings for 19 studies across six EPHPP domains plus overall risk of bias, with green for low risk, yellow for moderate risk, and red for high risk.</alt-text><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="ZEPT_A_2545734_F0002_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="ZEPT_A_2545734_F0002_PB.jpg"/></alternatives></fig></p></sec><sec disp-level="2" id="S003-S2004"><label>3.4.</label><title>Outcome measures</title><p>Outcome measures and timepoints of administration are presented in <xref rid="T0002" ref-type="table">Table 2</xref>. A total of 29 outcome measures were used across studies. These can be categorised into four domains of outcome measures assessing: dissociation, general mental health, psychopathology symptoms, and general functioning.
<table-wrap position="float" id="T0002" orientation="portrait"><label>Table 2.</label><caption><p>Outcome measures and timepoints of administration (<italic toggle="yes">k</italic>&#8201;=&#8201;19).</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/></colgroup><thead valign="bottom"><tr><th rowspan="2" align="left" colspan="1">Study</th><th colspan="4" align="center" rowspan="1">Outcome measure</th><th rowspan="2" align="center" colspan="1">Time-points</th></tr><tr><th align="center" colspan="1" rowspan="1">Dissociation</th><th align="center" colspan="1" rowspan="1">General mental health symptoms</th><th align="center" colspan="1" rowspan="1">Psychopathology</th><th align="center" colspan="1" rowspan="1">General functioning</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Choe and Kluft (<xref rid="CIT0011" ref-type="bibr">1995</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Pre, post</td></tr><tr><td align="left" colspan="1" rowspan="1">Boyd (<xref rid="CIT0005" ref-type="bibr">1997</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">MMPI</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Pre, post</td></tr><tr><td align="left" colspan="1" rowspan="1">Manchester et al. (<xref rid="CIT0028" ref-type="bibr">1998</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">MCMI</td><td align="left" colspan="1" rowspan="1">GAF</td><td align="left" colspan="1" rowspan="1">Pre, post, 12&#8211;36mfu</td></tr><tr><td align="left" colspan="1" rowspan="1">Coons and Bowman (<xref rid="CIT0013" ref-type="bibr">2001</xref>)</td><td align="left" colspan="1" rowspan="1">DES, DDFQ</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">BDI, PCL-5</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Pre, 10-year-fu</td></tr><tr><td align="left" colspan="1" rowspan="1">Gold et al. (<xref rid="CIT0017" ref-type="bibr">2001</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">MMPI</td><td align="left" colspan="1" rowspan="1">BDI, IES-R</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Pre, post</td></tr><tr><td align="left" colspan="1" rowspan="1">Sar et al. (<xref rid="CIT0046" ref-type="bibr">2002</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">CFIT</td><td align="left" colspan="1" rowspan="1">Pre, post</td></tr><tr><td align="left" colspan="1" rowspan="1">Ross and Haley (<xref rid="CIT0044" ref-type="bibr">2004</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">SCL-90-R</td><td align="left" colspan="1" rowspan="1">BHS, BSSI</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Pre, post, 3mfu</td></tr><tr><td align="left" colspan="1" rowspan="1">Humphreys et al. (<xref rid="CIT0018" ref-type="bibr">2005</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Pre, post</td></tr><tr><td align="left" colspan="1" rowspan="1">Kellett (<xref rid="CIT0022" ref-type="bibr">2005</xref>)</td><td align="left" colspan="1" rowspan="1">DES, SSD</td><td align="left" colspan="1" rowspan="1">BSI</td><td align="left" colspan="1" rowspan="1">BDI</td><td align="left" colspan="1" rowspan="1">IIP-32, PSQ</td><td align="left" colspan="1" rowspan="1">Pre, post, 6mfu</td></tr><tr><td align="left" colspan="1" rowspan="1">Gantt and Tinnin (<xref rid="CIT0016" ref-type="bibr">2007</xref>)</td><td align="left" colspan="1" rowspan="1">DES, DRS</td><td align="left" colspan="1" rowspan="1">SCL-45</td><td align="left" colspan="1" rowspan="1">IES-R, TAS</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Pre, post, 3mfu, 6mfu</td></tr><tr><td align="left" colspan="1" rowspan="1">Brand et al. (<xref rid="CIT0006" ref-type="bibr">2009</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">SCL-90-R</td><td align="left" colspan="1" rowspan="1">PCL-5</td><td align="left" colspan="1" rowspan="1">GAF, PITQ</td><td align="left" colspan="1" rowspan="1">5 time-points across therapy</td></tr><tr><td align="left" colspan="1" rowspan="1">Myrick et al. (<xref rid="CIT0032" ref-type="bibr">2012</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">SCL-90-R</td><td align="left" colspan="1" rowspan="1">PCL-5</td><td align="left" colspan="1" rowspan="1">PITQ</td><td align="left" colspan="1" rowspan="1">Pre, 6mfu, 18mfu, 30mfu</td></tr><tr><td align="left" colspan="1" rowspan="1">Jepsen et al. (<xref rid="CIT0020" ref-type="bibr">2014</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">SCL-90-R</td><td align="left" colspan="1" rowspan="1">BDI, IES-R</td><td align="left" colspan="1" rowspan="1">IIP-64</td><td align="left" colspan="1" rowspan="1">Pre, post, 12mfu</td></tr><tr><td align="left" colspan="1" rowspan="1">Brand and Loewenstein (<xref rid="CIT0007" ref-type="bibr">2014</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">SCL-90-R</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">GAF</td><td align="left" colspan="1" rowspan="1">4 time-points across therapy</td></tr><tr><td align="left" colspan="1" rowspan="1">Schiepek et al. (<xref rid="CIT0048" ref-type="bibr">2016</xref>)</td><td colspan="4" align="left" rowspan="1">Synergetic Model Feedback</td><td align="left" colspan="1" rowspan="1">Throughout treatment</td></tr><tr><td align="left" colspan="1" rowspan="1">Pollock et al. (<xref rid="CIT0036" ref-type="bibr">2017</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">BAI, BDI, ERSQ</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Pre, 3 timepoints across 14&#8197;m</td></tr><tr><td align="left" colspan="1" rowspan="1">Brand et al. (<xref rid="CIT1001" ref-type="bibr">2019</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">DERS, PCL-5</td><td align="left" colspan="1" rowspan="1">PITQ</td><td align="left" colspan="1" rowspan="1">Pre, 12mfu, 24mfu</td></tr><tr><td align="left" colspan="1" rowspan="1">Barbieri et al. (<xref rid="CIT0004" ref-type="bibr">2022</xref>)</td><td align="left" colspan="1" rowspan="1">DES</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">PCL-5</td><td align="left" colspan="1" rowspan="1">YSQ</td><td align="left" colspan="1" rowspan="1">Pre, mid-treatment, post, 6mfu</td></tr><tr><td align="left" colspan="1" rowspan="1">Baekkelund et al. (<xref rid="CIT0003" ref-type="bibr">2022</xref>)</td><td align="left" colspan="1" rowspan="1">DES, MID</td><td align="left" colspan="1" rowspan="1">SCL-90-R</td><td align="left" colspan="1" rowspan="1">PTSD-SS</td><td align="left" colspan="1" rowspan="1">GAF, IIP-32,</td><td align="left" colspan="1" rowspan="1">Pre, post, 6mfu</td></tr></tbody></table><table-wrap-foot><fn id="TF2"><p>Notes: BAI&#8201;=&#8201;Beck Anxiety Inventory; BDI&#8201;=&#8201;Beck Depression Inventory; BHS&#8201;=&#8201;Beck Hopelessness Scale; BSI&#8201;=&#8201;Beck Suicide Inventory; BSSI&#8201;=&#8201;Beck Scale for Suicidal Ideation; CFIT&#8201;=&#8201;Culture Fair Intelligence Test; DDFQ&#8201;=&#8201;Dissociative Disorders Follow-up Questionnaire; DES&#8201;=&#8201;Dissociative Experiences Scale; DERS&#8201;=&#8201;Difficulties in Emotion Regulation Scale; DRS&#8201;=&#8201;Dissociation Regression Scale; ERSQ&#8201;=&#8201;Emotion Regulation Skills Questionnaire; FU&#8201;=&#8201;Follow-up; GAF&#8201;=&#8201;Global Assessment of Functioning; IES-R&#8201;=&#8201;Impact of Event Scale-Revised; IIP-32&#8201;=&#8201;Inventory of Interpersonal Problems 32; IIP-64&#8201;=&#8201;Inventory of Interpersonal Problems 64; M&#8201;=&#8201;Month; MCMI&#8201;=&#8201;Million Clinical Multiaxial Inventory; MFU&#8201;=&#8201;Month follow-up; MMPI&#8201;=&#8201;Minnesota Multiphasic Personality Inventory; MID&#8201;=&#8201;Multidimensional Inventory of Dissociation; PSQ&#8201;=&#8201;Personality Structure Questionnaire; PCL-5&#8201;=&#8201;PTSD Checklist for DSM-V; PTSD-SS&#8201;=&#8201;PTSD Symptom Scale; PITQ&#8201;=&#8201;Progress in Treatment Questionnaire; SCL-45&#8201;=&#8201;Symptom Checklist-45; SCL-90-R&#8201;=&#8201;Symptom Checklist-90-Revised; SSD&#8201;=&#8201;State Scale of Dissociation; TAS&#8201;=&#8201;Toronto Alexithymia Scale; YSQ&#8201;=&#8201;Young Schema Questionnaire. Table summarising outcome measures used in 19 studies, listing dissociation, mental health, psychopathology, general functioning measures, and timing of assessments such as pre, post, and follow-up.</p></fn></table-wrap-foot></table-wrap></p><p><italic toggle="yes">Dissociation.</italic> Dissociation was assessed in 95% (<italic toggle="yes">k</italic>&#8201;=&#8201;18) of studies. Dissociation was assessed using five outcome measures, including the <italic toggle="yes">Dissociative Experiences Scale-II</italic> (DES-II) which was used in all studies measuring dissociation. Single studies used the <italic toggle="yes">Dissociative Regression Scale</italic>, <italic toggle="yes">Multidimensional Inventory of Dissociation</italic>, <italic toggle="yes">State Scale of Dissociation</italic>, and one &#8216;dissociative disorders follow-up questionnaire&#8217; created by Coons and Bowman (<xref rid="CIT0013" ref-type="bibr">2001</xref>) for the study.</p><p><italic toggle="yes">General mental health symptoms.</italic> General mental health symptoms were assessed in 53% (<italic toggle="yes">k</italic>&#8201;=&#8201;10) of studies; seven used the <italic toggle="yes">Symptoms Checklist-Revised;</italic> two used the <italic toggle="yes">Minnesota Multiphasic Personality Inventory</italic>, and one used the <italic toggle="yes">Brief Symptoms Inventory</italic>.</p><p><italic toggle="yes">Psychopathology.</italic> 13 studies assessed specific mental health symptoms; nine used PTSD-specific measures such as the <italic toggle="yes">Impact of Event Scale-Revised</italic> and <italic toggle="yes">PTSD Checklist</italic>. Six studies assessed depression using the <italic toggle="yes">Beck Depression Inventory</italic> and <italic toggle="yes">Beck Hopelessness Scale</italic>. A small number of studies assessed emotion regulation skills (<italic toggle="yes">k</italic>&#8201;=&#8201;2), anxiety (<italic toggle="yes">k</italic>&#8201;=&#8201;1), alexithymia (<italic toggle="yes">k</italic>&#8201;=&#8201;1), personality disorder (<italic toggle="yes">k</italic>&#8201;=&#8201;1), and suicidal ideation (<italic toggle="yes">k</italic>&#8201;=&#8201;1).</p><p><italic toggle="yes">General functioning.</italic> General functioning i.e. cognitive, social, and occupational functioning was assessed in 47% (<italic toggle="yes">k</italic>&#8201;=&#8201;9) of studies. Four studies used the <italic toggle="yes">Global Assessment of Functioning</italic> and three used the <italic toggle="yes">Progress in Treatment Questionnaire.</italic> Single studies used the <italic toggle="yes">Personality Structure Questionnaire</italic> and <italic toggle="yes">Young Schema Questionnaire</italic> and the <italic toggle="yes">Inventory of Interpersonal Problems (IIP).</italic> One study measured cognitions, emotions, and behaviours using a personalised questionnaire based on an idiographic system model, and one measured IQ using Cattell&#8217;s (<xref rid="CIT0008" ref-type="bibr">1949</xref>) <italic toggle="yes">Culture Fair Intelligence Test</italic>.</p></sec><sec disp-level="2" id="S003-S2005"><label>3.5.</label><title>Overview of treatment interventions</title><p>Treatment interventions are presented in <xref rid="T0003" ref-type="table">Table 3</xref>. Individual psychotherapy (<italic toggle="yes">k</italic>&#8201;=&#8201;16) was the most common, followed by group therapies (<italic toggle="yes">k</italic>&#8201;=&#8201;10).
<table-wrap position="float" id="T0003" orientation="portrait"><label>Table 3.</label><caption><p>Treatment approach, length, frequency, and facilitator (<italic toggle="yes">k</italic>&#8201;=&#8201;19)<italic toggle="yes">.</italic></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">Study</th><th align="center" colspan="1" rowspan="1">Treatment</th><th align="center" colspan="1" rowspan="1">Treatment length</th><th align="center" colspan="1" rowspan="1">Treatment frequency</th><th align="center" colspan="1" rowspan="1">Treatment facilitator</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Choe and Kluft (<xref rid="CIT0011" ref-type="bibr">1995</xref>)</td><td align="left" colspan="1" rowspan="1">Psychodynamic psychotherapy<break/>Hypnosis<break/>Group (art, cognitive, movement, verbal)</td><td align="left" colspan="1" rowspan="1">23 days</td><td align="center" colspan="1" rowspan="1">Individual: 5 sessions a week<break/>Group: up to 12 times a week</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Boyd (<xref rid="CIT0005" ref-type="bibr">1997</xref>)</td><td align="left" colspan="1" rowspan="1">Three-stage phase-oriented psychotherapy:<break/>Phase 1: assessment, stabilisation, mapping the system<break/>Phase 2: reducing trauma and dissociation symptoms, integrating identities, hypnosis<break/>Phase 3: relationships, individuation, finances and career</td><td align="left" colspan="1" rowspan="1">Stage 1: 5 sessions over 17 days<break/>Stage 2: 54 sessions over 10 months<break/>Stage 3: 52 sessions over 12 months</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Clinical psychologist</td></tr><tr><td align="left" colspan="1" rowspan="1">Manchester et al. (<xref rid="CIT0028" ref-type="bibr">1998</xref>)</td><td align="left" colspan="1" rowspan="1">Neurofeedback training<break/>Neurofeedback group</td><td align="left" colspan="1" rowspan="1">13&#8211;27 months<break/>Training: 30 sessions<break/>Group: 10 sessions</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Coons and Bowman (<xref rid="CIT0013" ref-type="bibr">2001</xref>)</td><td align="left" colspan="1" rowspan="1">Psychotherapy, journal writing, art therapy, psychotropic medication, hypnosis, counselling, psychoeducation, group, taping, hospitalisation, day therapy, vocational rehabilitation, marital therapy, electric convulsive therapy, family therapy, dance therapy, exorcism</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="center" colspan="1" rowspan="1">1&#8211;1.5 sessions a week</td><td align="left" colspan="1" rowspan="1">Therapists</td></tr><tr><td align="left" colspan="1" rowspan="1">Gold et al. (<xref rid="CIT0017" ref-type="bibr">2001</xref>)</td><td align="left" colspan="1" rowspan="1">Contextual therapy (interpersonal relating, self-understanding, skills transmission)</td><td align="left" colspan="1" rowspan="1">8&#8211;30 months</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Novice therapists</td></tr><tr><td align="left" colspan="1" rowspan="1">Sar et al. (<xref rid="CIT0046" ref-type="bibr">2002</xref>)</td><td align="left" colspan="1" rowspan="1">Psychotherapy (integrative, target trauma cognitions, contextual systemic factors)</td><td align="left" colspan="1" rowspan="1">18 months</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Ross and Haley (<xref rid="CIT0044" ref-type="bibr">2004</xref>)</td><td align="left" colspan="1" rowspan="1">Trauma model therapy:<break/>Individual and group therapy (attachment patterns, self-blame, correct cognitive errors and maladaptive beliefs, coping skills)</td><td align="left" colspan="1" rowspan="1">Mean 18.2 days</td><td align="center" colspan="1" rowspan="1">Individual: 3&#8197;h a week<break/>Group: 35&#8197;h a week</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Humphreys et al. (<xref rid="CIT0018" ref-type="bibr">2005</xref>)</td><td align="left" colspan="1" rowspan="1">Humanistic therapy (assimilation model of identities)</td><td align="left" colspan="1" rowspan="1">200 sessions over 3 years</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Student therapist</td></tr><tr><td align="left" colspan="1" rowspan="1">Kellett (<xref rid="CIT0022" ref-type="bibr">2005</xref>)</td><td align="left" colspan="1" rowspan="1">Cognitive analytic therapy</td><td align="left" colspan="1" rowspan="1">28 sessions over 53 weeks</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Gantt and Tinnin (<xref rid="CIT0016" ref-type="bibr">2007</xref>)</td><td align="left" colspan="1" rowspan="1">Intensive trauma treatment programme:<break/>Psychotherapy (psychoeducation, trauma processing, reversing dissociation, video recording/written tasks, modification of victim mythology)<break/>Group (art therapy)</td><td align="left" colspan="1" rowspan="1">1&#8211;2 weeks</td><td align="center" colspan="1" rowspan="1">7&#8197;h a day, 5 days a week</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Brand et al. (<xref rid="CIT0006" ref-type="bibr">2009</xref>)</td><td align="left" colspan="1" rowspan="1">Psychotherapy, group, family therapy, couples therapy, art therapy, other expressive therapies</td><td align="left" colspan="1" rowspan="1">Mean 5 years</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Therapists</td></tr><tr><td align="left" colspan="1" rowspan="1">Myrick et al. (<xref rid="CIT0032" ref-type="bibr">2012</xref>)</td><td align="left" colspan="1" rowspan="1">Psychotherapy, group, family therapy, couples therapy, art therapy, other expressive therapies</td><td align="left" colspan="1" rowspan="1">30 months</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Therapists</td></tr><tr><td align="left" colspan="1" rowspan="1">Jepsen et al. (<xref rid="CIT0020" ref-type="bibr">2014</xref>)</td><td align="left" colspan="1" rowspan="1">Specialised inpatient treatment programme for trauma-related symptoms in childhood sexual abuse survivors:<break/>Psychotherapy, group, movement therapy, expressive art, occupational therapy, physical training</td><td align="left" colspan="1" rowspan="1">3 months</td><td align="center" colspan="1" rowspan="1">Individual: 1&#8211;2 sessions a week<break/>Group: two sessions daily</td><td align="left" colspan="1" rowspan="1">Psychiatrists, clinical psychologists, nurses, occupational and art Therapists, social workers</td></tr><tr><td align="left" colspan="1" rowspan="1">Brand and Loewenstein (<xref rid="CIT0007" ref-type="bibr">2014</xref>)</td><td align="left" colspan="1" rowspan="1">Psychotherapy, group, family therapy, couples therapy, art therapy, other expressive therapies</td><td align="left" colspan="1" rowspan="1">Mean 5 years</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Therapists</td></tr><tr><td align="left" colspan="1" rowspan="1">Schiepek et al. (<xref rid="CIT0048" ref-type="bibr">2016</xref>)</td><td align="left" colspan="1" rowspan="1">Synergetic process management therapy (resource-focused interview, idiographic system model, individual psychotherapy, aftercare)</td><td align="left" colspan="1" rowspan="1">19 weeks</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Pollock et al. (<xref rid="CIT0036" ref-type="bibr">2017</xref>)</td><td align="left" colspan="1" rowspan="1">Three stage phase-oriented psychotherapy:<break/>Phase 1: psychoeducation, reduce self-destructive behaviour, self-care, increase safety<break/>Phase 2: processing trauma memories<break/>Phase 3: integration and maintaining identity, relearning relationship skills, tolerate stress, future goals</td><td align="left" colspan="1" rowspan="1">14 months<break/>Phase 1: 11 sessions<break/>Phase 2: 12 sessions<break/>Phase 3: 7 sessions</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Brand et al. (<xref rid="CIT1001" ref-type="bibr">2019</xref>)</td><td align="left" colspan="1" rowspan="1">Web-based psychoeducation programme (psychoeducation videos, video/written/behavioural exercises, symptom and emotion management techniques)</td><td align="left" colspan="1" rowspan="1">24 months</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Barbieri et al. (<xref rid="CIT0004" ref-type="bibr">2022</xref>)</td><td align="left" colspan="1" rowspan="1">Phase-oriented schema therapy (integrating CBT and NET techniques, skills training, expressive modalities)</td><td align="left" colspan="1" rowspan="1">85 sessions over 26 months</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Therapists</td></tr><tr><td align="left" colspan="1" rowspan="1">Baekkelund et al. (<xref rid="CIT0003" ref-type="bibr">2022</xref>)</td><td align="left" colspan="1" rowspan="1">Psychoeducation group</td><td align="left" colspan="1" rowspan="1">20 sessions</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Therapists</td></tr></tbody></table><table-wrap-foot><fn id="TF3"><p>Notes: &#8211;&#8201;=&#8201;not reported. CBT&#8201;=&#8201;cognitive-behavioural therapy; DDD&#8201;=&#8201;depersonalisation/derealisation disorder; NET&#8201;=&#8201;narrative exposure therapy. Table summarising 19 studies with details on treatment type, duration, session frequency, and professional facilitator roles such as therapists or psychologists.</p></fn></table-wrap-foot></table-wrap></p><p><italic toggle="yes">Individual psychotherapy.</italic> 84% (<italic toggle="yes">k</italic>&#8201;=&#8201;16) of studies used individual psychotherapy, with 8 types being used. PoT was most common (<italic toggle="yes">k</italic>&#8201;=&#8201;3). Two studies delivered three-stage PoT in line with ISSTD guidelines (Boyd, <xref rid="CIT0005" ref-type="bibr">1997</xref>; Pollock et al., <xref rid="CIT0036" ref-type="bibr">2017</xref>); one used phase-oriented schema therapy (Barbieri et al., <xref rid="CIT0004" ref-type="bibr">2022</xref>). Three studies used trauma-focused psychotherapy: one based on attachment theory and CBT (Ross &amp; Haley, <xref rid="CIT0044" ref-type="bibr">2004</xref>), one as part of an intensive treatment programme (Gantt &amp; Tinnin, <xref rid="CIT0016" ref-type="bibr">2007</xref>), and the third as part of a specialised inpatient programme for childhood sexual abuse survivors (Jepsen et al., <xref rid="CIT0020" ref-type="bibr">2014</xref>). Single studies used other individual psychotherapies, including psychodynamic psychotherapy (Choe &amp; Kluft, <xref rid="CIT0011" ref-type="bibr">1995</xref>), cognitive analytic therapy (CAT; Kellett, <xref rid="CIT0022" ref-type="bibr">2005</xref>), contextual therapy (Gold et al., <xref rid="CIT0017" ref-type="bibr">2001</xref>), psychoeducation (Brand et al., <xref rid="CIT1001" ref-type="bibr">2019</xref>), and humanistic therapy (Humphreys et al., <xref rid="CIT0018" ref-type="bibr">2005</xref>). Five studies used individual psychotherapy but did not specify modality.</p><p><italic toggle="yes">Group therapy.</italic> 53% (<italic toggle="yes">k</italic>&#8201;=&#8201;10) of studies used group therapies, with nine types. Five studies did not specify the type/focus of their intervention (Brand et al., <xref rid="CIT0006" ref-type="bibr">2009</xref>; Brand &amp; Loewenstein, <xref rid="CIT0007" ref-type="bibr">2014</xref>; Coons &amp; Bowman, <xref rid="CIT0013" ref-type="bibr">2001</xref>; Myrick et al., <xref rid="CIT0032" ref-type="bibr">2012</xref>; Ross &amp; Haley, <xref rid="CIT0044" ref-type="bibr">2004</xref>). Four studies used group interventions for couples/families (Brand et al., <xref rid="CIT0006" ref-type="bibr">2009</xref>; Brand &amp; Loewenstein, <xref rid="CIT0007" ref-type="bibr">2014</xref>; Coons &amp; Bowman, <xref rid="CIT0013" ref-type="bibr">2001</xref>; Myrick et al., <xref rid="CIT0032" ref-type="bibr">2012</xref>), and two used art therapy groups (Choe &amp; Kluft, <xref rid="CIT0011" ref-type="bibr">1995</xref>; Gantt &amp; Tinnin, <xref rid="CIT0016" ref-type="bibr">2007</xref>). Single studies used other group therapies: cognitive and movement (Choe &amp; Kluft, <xref rid="CIT0011" ref-type="bibr">1995</xref>), neurofeedback (Manchester et al., <xref rid="CIT0028" ref-type="bibr">1998</xref>), trauma-focused (Jepsen et al., <xref rid="CIT0020" ref-type="bibr">2014</xref>), psychoeducation (Baekkelund et al., <xref rid="CIT0003" ref-type="bibr">2022</xref>), and dance groups (Coons &amp; Bowman, <xref rid="CIT0013" ref-type="bibr">2001</xref>). Nine studies used group therapies alongside other interventions, only one study used group therapy as the sole intervention (Baekkelund et al., <xref rid="CIT0003" ref-type="bibr">2022</xref>). Five studies used multiple group therapies concurrently (Brand et al., <xref rid="CIT0006" ref-type="bibr">2009</xref>; Brand &amp; Loewenstein, <xref rid="CIT0007" ref-type="bibr">2014</xref>; Choe &amp; Kluft, <xref rid="CIT0011" ref-type="bibr">1995</xref>; Coons &amp; Bowman, <xref rid="CIT0013" ref-type="bibr">2001</xref>; Myrick et al., <xref rid="CIT0032" ref-type="bibr">2012</xref>).</p><p><italic toggle="yes">Other miscellaneous treatments.</italic> 53% (<italic toggle="yes">k</italic>&#8201;=&#8201;10) of studies used other treatments, comprising 19 types. One study contributed to a large proportion (12 treatments) of these (Coons &amp; Bowman, <xref rid="CIT0013" ref-type="bibr">2001</xref>). Hypnosis was used as an adjunct in 15% (<italic toggle="yes">k</italic>&#8201;=&#8201;3) of studies (Boyd, <xref rid="CIT0005" ref-type="bibr">1997</xref>; Choe &amp; Kluft, <xref rid="CIT0011" ref-type="bibr">1995</xref>; Coons &amp; Bowman, <xref rid="CIT0013" ref-type="bibr">2001</xref>). Single studies used treatments such as neurofeedback training (Manchester et al., <xref rid="CIT0028" ref-type="bibr">1998</xref>), web-based psychoeducation programme (Brand et al., <xref rid="CIT1001" ref-type="bibr">2019</xref>) synergetic process management therapy (Schiepek et al., <xref rid="CIT0048" ref-type="bibr">2016</xref>) and others. Three studies reported &#8216;other expressive therapies&#8217; without providing specific modality information (Brand et al., <xref rid="CIT0006" ref-type="bibr">2009</xref>; Brand &amp; Loewenstein, <xref rid="CIT0007" ref-type="bibr">2014</xref>; Myrick et al., <xref rid="CIT0032" ref-type="bibr">2012</xref>).</p><p><italic toggle="yes">Treatment length and frequency</italic>. All but one study (Coons &amp; Bowman, <xref rid="CIT0013" ref-type="bibr">2001</xref>) provided treatment length information, ranging from seven days to five years. The exception reported 1&#8211;1.5 treatment sessions per week. 26% (<italic toggle="yes">k</italic>&#8201;=&#8201;5) of studies provided treatment frequency. Individual treatment sessions ranged from 1 to 5 weekly; group therapy session varied from two daily (12 times a week) up to 35&#8197;h a week.</p></sec><sec disp-level="2" id="S003-S2006"><label>3.6.</label><title>Effectiveness of treatments</title><p>Clinical outcomes and effect sizes are presented in <xref rid="T0004" ref-type="table">Table 4</xref>. Outcomes of interest used to infer treatment effectiveness were dissociation symptoms, mental health symptoms, and general functioning; outcome measures with the most available data from studies are presented in <xref rid="F0003" ref-type="fig">Figure 3</xref>.
<fig position="float" id="F0003" orientation="portrait"><label>Figure 3.</label><caption><p>Pre- and post-treatment outcomes for measures of dissociation, general mental health, psychopathology, and general functioning.</p><p>Notes: Outcome measures depicted represent one study with the most available data from each of the four outcome domains, namely dissociation (a), general mental health (b), psychopathology (c), and general functioning (d). Dissociation outcome is indexed using the Dissociation Experiences Scale (DES; <italic toggle="yes">k</italic>&#8201;=&#8201;15); general mental health is indexed using the Symptom Checklist-90-Revised (SCL-90-R; <italic toggle="yes">k</italic>&#8201;=&#8201;5); psychopathology (depression) is indexed using the Beck Depression Inventory (BDI; <italic toggle="yes">k</italic>&#8201;=&#8201;6); and general functioning is indexed using the Global Assessment of Functioning (GAF; <italic toggle="yes">k</italic>&#8201;=&#8201;4). Standard errors are not presented when they were not reported in the citing paper.</p></caption><alt-text>Four-panel figure showing line graphs of pre- and post-treatment scores for dissociation, general mental health, psychopathology, and general functioning across studies, with different line styles representing intervention types and standard errors indicated where available.</alt-text><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="ZEPT_A_2545734_F0003_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="ZEPT_A_2545734_F0003_PB.jpg"/></alternatives></fig>
<table-wrap position="float" id="T0004" orientation="portrait"><label>Table 4.</label><caption><p>Clinical outcomes of the treatment approaches (<italic toggle="yes">k</italic>&#8201;=&#8201;19)<italic toggle="yes">.</italic></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">Treatment</th><th align="center" colspan="1" rowspan="1">Study</th><th align="center" colspan="1" rowspan="1">Dissociation outcomes</th><th align="center" colspan="1" rowspan="1">Mental health outcomes</th><th align="center" colspan="1" rowspan="1">General functioning outcomes</th></tr></thead><tbody><tr><td rowspan="3" align="left" colspan="1">Phase-oriented treatment</td><td align="left" colspan="1" rowspan="1">Boyd (<xref rid="CIT0005" ref-type="bibr">1997</xref>)</td><td align="left" colspan="1" rowspan="1">Decrease in DES from 48.2 at assessment to 2.0 at discharge. Self-reported identity unification. No longer met SCID-D DID diagnosis.</td><td align="center" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Improvements in quality of interpersonal relationships and subjective wellbeing/life functioning.</td></tr><tr><td align="left" colspan="1" rowspan="1">Pollock et al. (<xref rid="CIT0036" ref-type="bibr">2017</xref>)</td><td align="left" colspan="1" rowspan="1">No longer met DSM-IV DID diagnosis but still experiencing dissociation symptoms.</td><td align="left" colspan="1" rowspan="1">Improvements in depression and anxiety but still experiencing clinically significant symptoms.</td><td align="left" colspan="1" rowspan="1">Improvements in emotion regulation skills and reduced alcohol. Unchanged tiredness, low energy, sleep difficulties, and little interest in sex.</td></tr><tr><td align="left" colspan="1" rowspan="1">Barbieri et al. (<xref rid="CIT0004" ref-type="bibr">2022</xref>)</td><td align="left" colspan="1" rowspan="1">Improvements post-treatment.</td><td align="left" colspan="1" rowspan="1">Improvements in PTSD symptoms.</td><td align="left" colspan="1" rowspan="1">Improvements in schema domains disconnection/rejection, autonomy/performance, and vigilance/inhibition. Schema domain disconnection/rejection returned back to pre-treatment level at follow-up. Unchanged tiredness, low energy, and little interest in sex.</td></tr><tr><td rowspan="4" align="left" colspan="1">Individual psychotherapy</td><td align="left" colspan="1" rowspan="1">Gold et al. (<xref rid="CIT0017" ref-type="bibr">2001</xref>)</td><td align="left" colspan="1" rowspan="1">Improvements post-treatment.</td><td align="left" colspan="1" rowspan="1">Improvements in PTSD and depression symptoms.</td><td align="left" colspan="1" rowspan="1">Self-reported improvements in self-sufficiency, employment, and relationships.</td></tr><tr><td align="left" colspan="1" rowspan="1">Sar et al. (<xref rid="CIT0046" ref-type="bibr">2002</xref>)</td><td align="left" colspan="1" rowspan="1">Successful integration of alters.</td><td align="left" colspan="1" rowspan="1">Decrease in traumatic content scores.</td><td align="left" colspan="1" rowspan="1">Increased control over affective responses to environment and increased IQ scores from 90 to 124.</td></tr><tr><td align="left" colspan="1" rowspan="1">Kellett (<xref rid="CIT0022" ref-type="bibr">2005</xref>)</td><td align="left" colspan="1" rowspan="1">Improvements that were maintained and augmented at 6-month follow-up. Self-reported decreased sense of fragmentation.</td><td align="left" colspan="1" rowspan="1">Improvements in depression and OCD symptoms that were maintained at 6-month follow-up.</td><td align="left" colspan="1" rowspan="1">Self-reported improved ability to self-manage and capacity to work.</td></tr><tr><td align="left" colspan="1" rowspan="1">Humphreys et al. (<xref rid="CIT0018" ref-type="bibr">2005</xref>)</td><td align="left" colspan="1" rowspan="1">Successful integration of alters.</td><td align="center" colspan="1" rowspan="1">&#8211;</td><td align="center" colspan="1" rowspan="1">&#8211;</td></tr><tr><td rowspan="8" align="left" colspan="1">Multiple interventions<sup>x</sup></td><td align="left" colspan="1" rowspan="1">Choe and Kluft (<xref rid="CIT0011" ref-type="bibr">1995</xref>)</td><td align="left" colspan="1" rowspan="1">Improvements in absorption, changeability, and depersonalisation/derealisation scores, but increase in amnesia.</td><td align="center" colspan="1" rowspan="1">&#8211;</td><td align="center" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Coons and Bowman (<xref rid="CIT0013" ref-type="bibr">2001</xref>)</td><td align="left" colspan="1" rowspan="1">Increase in identity unification. 33% became fully integrated. Decrease in number of identity states among those who remained unintegrated.</td><td align="left" colspan="1" rowspan="1">Integrated participants showed improvements in PTSD, depression, and somatoform symptoms. No improvements among unintegrated participants.</td><td align="center" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Ross and Haley (<xref rid="CIT0044" ref-type="bibr">2004</xref>)</td><td align="left" colspan="1" rowspan="1">Improvements post-treatment (<italic toggle="yes">d</italic>&#8201;=&#8201;0.63).</td><td align="left" colspan="1" rowspan="1">Improvements in overall psychological distress (<italic toggle="yes">d</italic>&#8201;=&#8201;1.25), depression (<italic toggle="yes">d</italic>&#8201;=&#8201;1.66), hopelessness (<italic toggle="yes">d</italic>&#8201;=&#8201;1.17), and suicidal ideation (<italic toggle="yes">d</italic>&#8201;=&#8201;1.12). Reductions in the number of suicide attempts and hospitalisations. Reductions were all sustained at 3-month follow-up except for hopelessness (<italic toggle="yes">d</italic>&#8201;<italic toggle="yes">=</italic>&#8201;&#8722;0.05).</td><td align="center" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Gantt and Tinnin (<xref rid="CIT0016" ref-type="bibr">2007</xref>)</td><td align="left" colspan="1" rowspan="1">Improvements post-treatment.</td><td align="left" colspan="1" rowspan="1">Improvements in overall psychological distress, PTSD, and alexithymia symptoms</td><td align="center" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Brand et al. (<xref rid="CIT0006" ref-type="bibr">2009</xref>)</td><td align="left" colspan="1" rowspan="1">Improvements post-treatment (<italic toggle="yes">d</italic>&#8201;=&#8201;0.64).</td><td align="left" colspan="1" rowspan="1">Improvements in overall psychological distress (<italic toggle="yes">d</italic>&#8201;=&#8201;0.71) and PTSD (<italic toggle="yes">d</italic>&#8201;=&#8201;1.00) symptoms, but still experiencing clinically significant levels of PTSD. Reductions in self-harm, suicidal ideation/attempts, and hospitalisations.</td><td align="left" colspan="1" rowspan="1">Improved ability to manage affect, impulses, symptoms, and relationships (<italic toggle="yes">d</italic>&#8201;=&#8201;1.61). Better social and work functioning.</td></tr><tr><td align="left" colspan="1" rowspan="1">Myrick et al. (<xref rid="CIT0032" ref-type="bibr">2012</xref>)</td><td align="left" colspan="1" rowspan="1">Improvements post-treatment.</td><td align="left" colspan="1" rowspan="1">Improvements in PTSD symptoms. Reductions in self-harm, suicidal ideation/attempts, and hospitalisations. Younger adults improved at a quicker pace than older adults.</td><td align="center" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Jepsen et al. (<xref rid="CIT0020" ref-type="bibr">2014</xref>)</td><td align="left" colspan="1" rowspan="1">No effect (<italic toggle="yes">d</italic>&#8201;=&#8201;0.09).</td><td align="left" colspan="1" rowspan="1">Small improvements in overall psychological distress (<italic toggle="yes">d</italic>&#8201;=&#8201;0.28) and depression (<italic toggle="yes">d</italic>&#8201;=&#8201;0.19); medium improvements in PTSD symptoms (<italic toggle="yes">d</italic>&#8201;=&#8201;0.59).</td><td align="center" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Brand and Loewenstein (<xref rid="CIT0007" ref-type="bibr">2014</xref>)</td><td align="left" colspan="1" rowspan="1">Improvements in voice hearing of dissociated self-states, including subjective self-division and hearing voices of self-states.</td><td align="left" colspan="1" rowspan="1">Improvements in overall psychological distress.</td><td align="left" colspan="1" rowspan="1">Participants became more functional over the course of treatment.</td></tr><tr><td rowspan="4" align="left" colspan="1">Other treatments<sup>y</sup></td><td align="left" colspan="1" rowspan="1">Manchester et al. (<xref rid="CIT0028" ref-type="bibr">1998</xref>)</td><td align="left" colspan="1" rowspan="1">100% reported identity unification. Dissociation scores within normal parameters at one-year follow-up.</td><td align="left" colspan="1" rowspan="1">All participants free from PTSD symptoms post-treatment and these improvements sustained at follow-up. Group process of treatment made them feel less alone, less isolated, and instilled sense of hope.</td><td align="center" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1">Schiepek et al. (<xref rid="CIT0048" ref-type="bibr">2016</xref>)</td><td align="center" colspan="1" rowspan="1">&#8211;</td><td align="center" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Positive effects on identity development and autonomy in life.</td></tr><tr><td align="left" colspan="1" rowspan="1">Brand et al. (<xref rid="CIT1001" ref-type="bibr">2019</xref>)</td><td align="left" colspan="1" rowspan="1">Medium improvements (<italic toggle="yes">d</italic>&#8201;=&#8201;0.48). High dissociation group showed large improvements (<italic toggle="yes">d</italic>&#8201;=&#8201;0.81); low dissociation group showed small improvements (<italic toggle="yes">d</italic>&#8201;=&#8201;0.24).</td><td align="left" colspan="1" rowspan="1">Medium improvements in PTSD symptoms (<italic toggle="yes">d</italic>&#8201;=&#8201;0.65) and reduced reports of self-injury. High dissociation group showed large improvements in PTSD symptoms (<italic toggle="yes">d</italic>&#8201;=&#8201;0.93); low dissociation group showed small improvements (<italic toggle="yes">d</italic>&#8201;=&#8201;0.32).</td><td align="left" colspan="1" rowspan="1">Large improvements in emotion regulation (<italic toggle="yes">d</italic>&#8201;=&#8201;0.90) and adaptive capacities (<italic toggle="yes">d</italic>&#8201;=&#8201;0.86). High dissociation group showed large improvements in emotion regulation (<italic toggle="yes">d</italic>&#8201;=&#8201;1.04) and adaptive capacities (<italic toggle="yes">d</italic>&#8201;=&#8201;0.94). Low dissociation group showed medium-approaching-large improvements in emotion regulation (<italic toggle="yes">d</italic>&#8201;=&#8201;0.74) and adaptive capacities (<italic toggle="yes">d</italic>&#8201;=&#8201;0.75). Most participants reported ongoing symptoms that required further treatment.</td></tr><tr><td align="left" colspan="1" rowspan="1">Baekkelund et al. (<xref rid="CIT0003" ref-type="bibr">2022</xref>)</td><td align="left" colspan="1" rowspan="1">Minimal effect post-treatment (<italic toggle="yes">d</italic>&#8201;=&#8201;&#8722;0.10) and at 6-month follow-up (<italic toggle="yes">d</italic>&#8201;=&#8201;&#8722;0.10).</td><td align="left" colspan="1" rowspan="1">Minimal effect on overall psychological distress (<italic toggle="yes">d</italic>&#8201;=&#8201;0.10) and no effect on PTSD symptoms (<italic toggle="yes">d</italic>&#8201;=&#8201;0.0) post-treatment. Minimal effect on overall psychological distress (<italic toggle="yes">d</italic>&#8201;=&#8201;0.10) and PTSD symptoms (<italic toggle="yes">d</italic>&#8201;=&#8201;&#8722;0.10) at 6-month follow-up.</td><td align="left" colspan="1" rowspan="1">Small-approaching-medium effect on adaptive functioning post-treatment (<italic toggle="yes">d</italic>&#8201;=&#8201;0.4) but large effect at 6-month follow-up (<italic toggle="yes">d</italic>&#8201;=&#8201;1.10). Most participants reported ongoing symptoms that required further treatment.</td></tr></tbody></table><table-wrap-foot><fn id="TF4"><p>Notes: &#8211;&#8201;=&#8201;not reported. DES&#8201;=&#8201;dissociative experiences scale; DID&#8201;=&#8201;dissociative identity disorder; DSM-IV&#8201;=&#8201;Diagnostic and Statistical Manual of Mental Disorders, 4th Edition; IQ&#8201;=&#8201;Intelligence quotient; OCD&#8201;=&#8201;obsessive compulsive disorder; PTSD&#8201;=&#8201;post-traumatic stress disorder; SCID-D&#8201;=&#8201;Structured Clinical Interview for Dissociative Disorders; <sup>x</sup>&#8201;=&#8201;Psychotherapy, journal writing, art therapy, mediation, hypnosis, counselling, psychoeducation, group, taping, hospitalisation, day therapy, vocational rehabilitation, marital therapy, electric convulsive therapy, family therapy, dance therapy, exorcism, other expressive therapies; <sup>y</sup>&#8201;=&#8201;neurofeedback training, web-based psychoeducation programme; psychoeducation-based group, synergetic process management therapy. Table summarising dissociation, mental health, and general functioning outcomes reported in 19 included studies, grouped by treatment type.</p></fn></table-wrap-foot></table-wrap></p><p><italic toggle="yes">Phase oriented treatment.</italic> The three studies that delivered PoT all reported improvements in dissociation. Two found that participants self-reported personality unification and no longer met DID criteria, but were still experiencing dissociation post-treatment. The two studies that assessed mental health symptoms found improvements in depression, anxiety, and PTSD. One study found that participants were still experiencing depression and PTSD symptoms post-treatment. The three studies that assessed general functioning found improvements in quality of interpersonal relationships, subjective wellbeing, emotion regulation, and alcohol use. One study found improvements in schema domains of disconnection/rejection, autonomy/performance, and vigilance/inhibition. However, one study found unchanging symptoms of tiredness and little interest in sex, and another found that some cognitive domains, such as disconnection/rejection, returned back to pre-treatment levels at 6-month follow-up.</p><p><italic toggle="yes">Individual psychotherapy.</italic> The four studies that delivered individual psychotherapies all found improvements in dissociation, and two studies reported personality unification. Concerning mental health symptoms, contextual therapy improved post-traumatic and depression symptoms, integrative psychotherapy decreased traumatic content scores, and CAT produced improvements in depression and obsessive-compulsive disorder (OCD) symptoms that were sustained at 6-month follow-up. For general functioning, contextual therapy improved self-sufficiency, relationships, and employment, CAT improved ability to self-manage and capacity to work, and integrative psychotherapy improved control over affective response and IQ. Contextual therapy produced improvements within timeframes that are considered brief compared to the three-to-five year course of treatment commonly projected for DID (Myrick et al., <xref rid="CIT0033" ref-type="bibr">2017</xref>).</p><p><italic toggle="yes">Multiple interventions.</italic> Seven out of eight studies found positive effects of multiple interventions on dissociation. One study found reductions in absorption, changeability, and depersonalisation/derealisation scores, but an increase in amnesia. One study reported reduced voice hearing of dissociated self-states, and another found increased identity unification. One study found that 33% of participants became fully integrated, and for those who remained unintegrated, the number of identities decreased from a mean of 15&#8211;7. They also found that participants who became integrated showed improvements in depression, somatoform and PTSD symptoms whereas unintegrated participants did not. However, the specialised inpatient trauma programme found little effect on dissociation during the treatment period but larger improvements at follow-up. The six studies that assessed mental health symptoms all found significant improvements. PTSD was the most commonly improved symptom with five studies reporting improvements. Three studies found improvements in depression symptoms, and three studies found reductions in self-harm, suicidal ideation/attempts and hospitalisations. Single studies found improvements in somatoform and alexithymia symptoms. One study found large effect sizes on all domains except for hopelessness were sustained from post-treatment to follow-up. One study only found improvements in mental health among those who became fully integrated. Concerning general functioning, the two studies that assessed for this found improvements in ability to manage affect, relationships, and social/work functioning with large effect sizes. Three studies found that participant age was a predictor of treatment outcomes: younger adults were more impaired pre-treatment but responded to treatment at a quicker pace.</p><p><italic toggle="yes">Other treatments.</italic> From the three studies that delivered other treatments, two found positive outcomes on dissociation symptoms. One study found that neurofeedback training led to all participants being unified post-treatment. Another study found moderate improvements in dissociation symptoms after a 24-month web-based psychoeducation programme. However, another study found that a 20-session psychoeducation-based group had little effect on dissociation post-treatment and at 6-month follow-up. Concerning mental health symptoms, the same three studies all reported improvements in PTSD symptoms. However, one study found minimal effect of the psychoeducation-based group on overall psychological distress. Concerning general functioning, the web-based psychoeducation programme improved emotion regulation and adaptive capacities with large effect sizes. Synergetic process management therapy produced positive outcomes on identity development and autonomy, and the psychoeducation group found small-approaching-medium effects on psychosocial functioning post-treatment but large effects at 6-month follow-up.</p><p>A subjective assessment of the data indicate that all treatment types produced clinically significant improvements in at least one of the four assessed domains from pre- to post-treatment. When comparing treatment types, a visual inspection of the available data presented in <xref rid="F0003" ref-type="fig">Figure 3</xref> suggests that PoT and individual psychotherapy produced the strongest effects on domains of dissociation and psychopathology (depression) from pre- to post-treatment. Multiple interventions and other treatments produced less pronounced effects on these two domains but stronger effects on the domain of general functioning.</p></sec></sec><sec sec-type="discussion" disp-level="1" id="S004"><label>4.</label><title>Discussion</title><p>The review summarises the findings of 19 treatment studies, wherein three evaluated the efficacy of phase-oriented treatment (PoT) in dissociative disorders (DDs). Comparatively, four studies delivered individual psychotherapies, eight delivered multiple interventions concomitantly, and four used other treatments. Our most important finding is that all studies, irrespective of treatment type, found clinically significant improvements in at least one of the four assessed domains (dissociation, mental health, psychopathology, and general functioning) when comparing pre- to post-treatment.</p><p>A visual assessment of the data indicate that each treatment type has its strengths depending on the outcome of interest. The most significant improvements appear for PoT and individual psychotherapy, which produced the most favourable outcomes on dissociation and psychopathology respectively; this is in line with these treatments focusing on symptom stabilisation and trauma processing (ISSTD, <xref rid="CIT0019" ref-type="bibr">2011</xref>). Multiple interventions were most effective for general mental health, while other treatment approaches such as group interventions better targeted general functioning; this makes logical sense given that this domain taps into cognitive, social, and occupational functioning. The only RCT in the review found minimal effects on outcomes post-treatment but reported positive outcomes on mental health and general functioning at 6-month follow-up. Although this was a psychoeducation-based group as opposed to a full course of psychotherapy, these findings provide evidence against the iatrogenic theory that DID treatment is not only ineffective but harmful and dissociative symptoms would increase instead of decrease (Lilienfeld, <xref rid="CIT0026" ref-type="bibr">2007</xref>). However, most studies were uncontrolled case studies/series without a comparison/control group, so empirical conclusions regarding treatment efficacy should be interpreted with caution.</p><p>Concerning maintenance of treatment gains and longer-term outcomes, all studies except one found sustained or augmented improvements at follow-up. However, the only study to deliver PoT and collect follow-up outcomes found that improvements in schema domains of disconnection/rejection returned back to pre-treatment levels at 6-month follow-up. Nevertheless, it is important to note the nonlinearity of treatment especially of DID patients. Due to the phasic nature of treatment, many find themselves re-traumatised from new emerging knowledge about the traumatic past. The therapist explores the patient's unconscious trauma-related knowledge which may be a cause of maladaptive functioning until that information is integrated. Integrating traumatic memories brings together the different aspects of traumatic experiences, memories and sequence of events, associated affects and physiological and somatic representations (Subramanyam et al., <xref rid="CIT0051" ref-type="bibr">2020</xref>). In doing so, progress assessed through outcome measures at a short 6-month follow up does not provide an adequate representation, requiring longer timeframes of assessment. Nonetheless, this review demonstrates that DD treatment broadly is not only efficacious but can be sustained and even augmented over time. This supports the hypothesis that individuals with DDs may require more time to consolidate therapeutic material and show improvements (Jepsen et al., <xref rid="CIT0020" ref-type="bibr">2014</xref>).</p><p>Few studies reported on treatment acceptability. Four studies reported dropout rates ranging from 3&#8211;23%. Two studies gathered qualitative feedback from participants; this was extremely positive in both studies. Baekkelund et al. (<xref rid="CIT0003" ref-type="bibr">2022</xref>) found that dropout was higher for participants with higher dissociation scores pre-treatment. Concerning qualitative feedback, Manchester et al. (<xref rid="CIT0028" ref-type="bibr">1998</xref>) completed post-treatment interviews and 100% of participants reported that the group intervention made them feel less alone/isolated and instilled hope for recovery. Brand et al. (<xref rid="CIT1001" ref-type="bibr">2019</xref>) received feedback from participants and therapists that the web-based psychoeducation programme content was relevant, clear, and useful for participants struggling with safety and symptom stabilisation. Though limited, this information suggests acceptability of DD treatment. This is of interest as many patients with a dissociative pathology share a history of years of misdiagnoses, inefficient treatment and repeated hospitalisations (Reinders et al., <xref rid="CIT0040" ref-type="bibr">2019</xref>). Evidence indicates that pathological dissociation is a negative predictor of psychotherapy response in various pathological samples (Lanius, <xref rid="CIT0025" ref-type="bibr">2015</xref>; Spitzer et al., <xref rid="CIT0049" ref-type="bibr">2007</xref>), which can be attributed to years of incorrect treatment, protracted personal suffering and high direct and indirect societal costs (Myrick et al., <xref rid="CIT0033" ref-type="bibr">2017</xref>; Reinders et al., <xref rid="CIT0040" ref-type="bibr">2019</xref>) as well as inadequate professional training and management of DDs (Chien &amp; Fung, <xref rid="CIT0010" ref-type="bibr">2022</xref>). This maintains the need for reputable research evidence and continued research support in the field of DDs to educate and highlight the complexity trauma-related pathological dissociation.</p><p>Despite positive outcomes, most participants across studies continued to experience clinically significant symptoms post-treatment that required further intervention. Complex presentations and extensive comorbidities are common in DDs, which results in diagnostic and therapeutic challenges (Chien &amp; Fung, <xref rid="CIT0010" ref-type="bibr">2022</xref>). This is unsurprising given that individuals with DDs typically experience years of childhood abuse, high degrees of impairment, and require many years of treatment (Raison &amp; Andrea, <xref rid="CIT0039" ref-type="bibr">2023</xref>). Moreover, many individuals never achieve complete identity reintegration but strive towards optimal integration so they can have adequate daily functioning (Pais, <xref rid="CIT0035" ref-type="bibr">2009</xref>). Four studies in this review achieved positive outcomes in short timeframes and are of specific interest for the patient&#8217;s quality of life and cost-effectiveness.</p><sec disp-level="2" id="S004-S2001"><label>4.1.</label><title>Strengths and limitations</title><p>This is the first systematic review to investigate treatment approaches for DID/OSDD and the efficacy of PoT more broadly. A limitation of the current review was that most included studies were case studies/series and this lack of control/comparison groups means it is not possible to causally attribute symptom reduction to treatment. Such designs are inherently limited in terms of internal and external validity, which compromises the strength and generalisability of the conclusions drawn. However, given that DDs typically persist for decades (Loewenstein et al., <xref rid="CIT0027" ref-type="bibr">2024</xref>) it seems implausible that patients would improve so quickly due to spontaneous remission/other factors. Another limitation is that only three studies evaluated the effects of PoT. While all studies used pre- and post-treatment outcome measures, each study used different measures for different treatments in different settings. Therefore, results of this study are based on careful inspection of visual interpretations of the data. Methodological limitations are corroborated by EPHPP ratings; 11 studies were rated as weak and only two as strong.</p></sec><sec disp-level="2" id="S004-S2002"><label>4.2.</label><title>Future research</title><p>The next step is to conduct high quality RCTs in order to (1) further assess treatment efficacy, (2) build an evidence base for how best to treat DDs, and (3) support the use of treatment in clinical practice. Future studies should include the voices of those with DDs by collecting post-treatment feedback via qualitative interviews or measures of treatment acceptability. The economic costs associated with DDs and their treatment is understudied (Myrick et al., <xref rid="CIT0033" ref-type="bibr">2017</xref>; Reinders et al., <xref rid="CIT0040" ref-type="bibr">2019</xref>). Future research should synthesise the evidence on the clinical effectiveness and economic outcomes of DD treatment to guide practice and policy decisions. Furthermore, it has been recommended that brain imaging be used to study the neurobiological correlates of treatment intervention. In turn, results can guide innovative psychological and pharmacological treatment approaches (Purcell et al., <xref rid="CIT0037" ref-type="bibr">2024</xref>; Reinders et al., <xref rid="CIT0042" ref-type="bibr">2022</xref>, <xref rid="CIT0043" ref-type="bibr">2023</xref>).</p></sec></sec><sec sec-type="conclusions" disp-level="1" id="S005"><label>5.</label><title>Conclusions</title><p>This systematic review explored the efficacy of PoT and other treatments for individuals with DID/OSDD. The study found that all treatment types produced clinically significant improvements in at least one domain of dissociation, psychopathology, mental health, and general functioning, and these were largely sustained/augmented at follow-up. As such, this study provides emerging evidence to support the use of psychological interventions, including PoT, for DDs.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="SM7234" position="float" content-type="local-data" orientation="portrait"><caption><title>Supplementary materials.docx</title></caption><media xlink:href="ZEPT_A_2545734_SM7234.docx" position="float" orientation="portrait"/></supplementary-material></sec></body><back><sec sec-type="COI-statement" disp-level="1" id="S006"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the author(s).</p></sec><sec sec-type="data-availability" disp-level="1" id="S007"><title>Data availability statement</title><p>The data supporting the findings of this systematic review are available in the published articles found in the reference list and supplementary materials.</p></sec><sec sec-type="supplementary-material" id="s008"><title>Supplemental Material</title><p>Supplemental data for this article can be accessed online at <ext-link xlink:href="10.1080/20008066.2025.2545734" ext-link-type="doi">https://doi.org/10.1080/20008066.2025.2545734</ext-link>.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>American Psychiatric Association</collab></person-group>. (<year>2013</year>). <source><italic toggle="yes">Diagnostic and statistical manual of mental disorders</italic></source> (<edition>5th ed</edition>.).</mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Armijo-Olivo</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Stiles</surname>, <given-names>C. R.</given-names></string-name>, <string-name name-style="western"><surname>Hagen</surname>, <given-names>N. A.</given-names></string-name>, <string-name name-style="western"><surname>Biondo</surname>, <given-names>P. D.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Cummings</surname>, <given-names>G. G.</given-names></string-name></person-group> (<year>2012</year>). <article-title>Assessment of study quality for systematic reviews: A comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: Methodological research</article-title>. <source><italic toggle="yes">Journal of Evaluation in Clinical Practice</italic></source>, <volume><italic toggle="yes">18</italic></volume>(<issue>1</issue>), <fpage>12</fpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2753.2010.01516.x</pub-id><pub-id pub-id-type="pmid">20698919</pub-id></mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Baekkelund</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Ulvenes</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Boon-Langelaan</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Arnevik</surname>, <given-names>E. A.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Group treatment for complex dissociative disorders: A randomized clinical trial</article-title>. <source><italic toggle="yes">BMC Psychiatry</italic></source>, <volume><italic toggle="yes">22</italic></volume>(<issue>1</issue>), <fpage>338</fpage>. <pub-id pub-id-type="doi">10.1186/s12888-022-03970-8</pub-id><pub-id pub-id-type="pmid">35578194</pub-id><pub-id pub-id-type="pmcid">PMC9112598</pub-id></mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Barbieri</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Visco-Comandini</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Trianni</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Saliani</surname>, <given-names>A. M.</given-names></string-name></person-group> (<year>2022</year>). <article-title>A schema therapy approach to complex dissociative disorder in a cross-cultural setting: A single case study</article-title>. <source><italic toggle="yes">Rivista di Psichiatria</italic></source>, <volume><italic toggle="yes">57</italic></volume>(<issue>3</issue>), <fpage>141</fpage>&#8211;<lpage>157</lpage>.<pub-id pub-id-type="pmid">35695685</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1708/3814.37993</pub-id></mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boyd</surname>, <given-names>J. D.</given-names></string-name></person-group> (<year>1997</year>). <article-title>Clinical hypnosis for rapid recovery from dissociative identity disorder</article-title>. <source><italic toggle="yes">The American Journal of Clinical Hypnosis</italic></source>, <volume><italic toggle="yes">40</italic></volume>(<issue>2</issue>), <fpage>97</fpage>&#8211;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1080/00029157.1997.10403414</pub-id><pub-id pub-id-type="pmid">9385721</pub-id></mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Brand</surname>, <given-names>B. L.</given-names></string-name>, <string-name name-style="western"><surname>Classen</surname>, <given-names>C. C.</given-names></string-name>, <string-name name-style="western"><surname>Lanius</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Loewenstein</surname>, <given-names>R. J.</given-names></string-name>, <string-name name-style="western"><surname>McNary</surname>, <given-names>S. W.</given-names></string-name>, <string-name name-style="western"><surname>Pain</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Putnam</surname>, <given-names>F. W.</given-names></string-name></person-group> (<year>2009</year>). <article-title>A naturalistic study of dissociative identity disorder and dissociative disorder not otherwise specified patients treated by community clinicians</article-title>. <source><italic toggle="yes">Psychological Trauma: Theory, Research, Practice, and Policy</italic></source>, <volume><italic toggle="yes">1</italic></volume>(<issue>2</issue>), <fpage>153</fpage>&#8211;<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1037/a0016210</pub-id></mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Brand</surname>, <given-names>B. L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Loewenstein</surname>, <given-names>R. J.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Does phasic trauma treatment make patients with dissociative disorder treatment more dissociative?</article-title><source><italic toggle="yes">Journal of Trauma &amp; Dissociation</italic></source>, <volume><italic toggle="yes">15</italic></volume>(<issue>1</issue>), <fpage>52</fpage>&#8211;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1080/15299732.2013.828150</pub-id><pub-id pub-id-type="pmid">24377972</pub-id></mixed-citation></ref><ref id="CIT1001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Brand</surname>, <given-names>B. L.</given-names></string-name>, <string-name name-style="western"><surname>Schielke</surname>, <given-names>H. J.</given-names></string-name>, <string-name name-style="western"><surname>Putnam</surname>, <given-names>K. T.</given-names></string-name>, <string-name name-style="western"><surname>Putnam</surname>, <given-names>F. W.</given-names></string-name>, <string-name name-style="western"><surname>Loewenstein</surname>, <given-names>R. J.</given-names></string-name>, <string-name name-style="western"><surname>Myrick</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Jepsen</surname>, <given-names>E. K. K.</given-names></string-name>, <string-name name-style="western"><surname>Langeland</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Steele</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Classen</surname>, <given-names>C. C.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Lanius</surname>, <given-names>R. A.</given-names></string-name></person-group> (<year>2019</year>). <article-title>An online educational program for individuals with dissociative disorders and their clinicians: 1-year and 2-year follow-up</article-title>. <source><italic toggle="yes">Journal of Traumatic Stress</italic></source>, <volume><italic toggle="yes">32</italic></volume>(<issue>1</issue>), <fpage>156</fpage>&#8211;<lpage>166</lpage>.<pub-id pub-id-type="pmid">30698858</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jts.22370</pub-id><pub-id pub-id-type="pmcid">PMC6590319</pub-id></mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Cattell</surname>, <given-names>R. B.</given-names></string-name></person-group> (<year>1949</year>). <source><italic toggle="yes">The culture fair intelligence test</italic></source>. <publisher-name>Institute for Personality and Ability Testing</publisher-name>.</mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chalavi</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Vissia</surname>, <given-names>E. M.</given-names></string-name>, <string-name name-style="western"><surname>Giesen</surname>, <given-names>M. E.</given-names></string-name>, <string-name name-style="western"><surname>Nijenhuis</surname>, <given-names>E. R.</given-names></string-name>, <string-name name-style="western"><surname>Draijer</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Cole</surname>, <given-names>J. H.</given-names></string-name>, <string-name name-style="western"><surname>Dazzan</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Pariante</surname>, <given-names>C. M.</given-names></string-name>, <string-name name-style="western"><surname>Madsen</surname>, <given-names>S. K.</given-names></string-name>, <string-name name-style="western"><surname>Rajagopalan</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname>, <given-names>P. M.</given-names></string-name>, <string-name name-style="western"><surname>Toga</surname>, <given-names>A. W.</given-names></string-name>, <string-name name-style="western"><surname>Veltman</surname>, <given-names>D. J.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Reinders</surname>, <given-names>A. A.</given-names></string-name></person-group> (<year>2015</year>). <article-title>Abnormal hippocampal morphology in dissociative identity disorder and post-traumatic stress disorder correlates with childhood trauma and dissociative symptoms</article-title>. <source><italic toggle="yes">Human Brain Mapping</italic></source>, <volume><italic toggle="yes">36</italic></volume>(<issue>5</issue>), <fpage>1692</fpage>&#8211;<lpage>1704</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.22730</pub-id><pub-id pub-id-type="pmid">25545784</pub-id><pub-id pub-id-type="pmcid">PMC4400262</pub-id></mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chien</surname>, <given-names>W. T.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Fung</surname>, <given-names>H. W.</given-names></string-name></person-group> (<year>2022</year>). <article-title>The challenges in diagnosis and treatment of dissociative disorders</article-title>. <source><italic toggle="yes">Alpha Psychiatry</italic></source>, <volume><italic toggle="yes">23</italic></volume>(<issue>2</issue>), <fpage>45</fpage>&#8211;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.5152/alphapsychiatry.2022.0001</pub-id><pub-id pub-id-type="pmid">36426292</pub-id><pub-id pub-id-type="pmcid">PMC9597071</pub-id></mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Choe</surname>, <given-names>B. M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Kluft</surname>, <given-names>R. P.</given-names></string-name></person-group> (<year>1995</year>). <article-title>The use of the DES in studying treatment outcome with dissociative identity disorder: A pilot study</article-title>. <source><italic toggle="yes">Dissociation: Progress in the Dissociative Disorders</italic></source>, <volume><italic toggle="yes">8</italic></volume>(<issue>3</issue>), <fpage>160</fpage>&#8211;<lpage>164</lpage>.</mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Coons</surname>, <given-names>P. M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Bowman</surname>, <given-names>E. S.</given-names></string-name></person-group> (<year>2001</year>). <article-title>Ten-year follow-up study of patients with dissociative identity disorder</article-title>. <source><italic toggle="yes">Journal of Trauma &amp; Dissociation</italic></source>, <volume><italic toggle="yes">2</italic></volume>(<issue>1</issue>), <fpage>73</fpage>&#8211;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1300/J229v02n01_09</pub-id></mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dalenberg</surname>, <given-names>C. J.</given-names></string-name>, <string-name name-style="western"><surname>Brand</surname>, <given-names>B. L.</given-names></string-name>, <string-name name-style="western"><surname>Gleaves</surname>, <given-names>D. H.</given-names></string-name>, <string-name name-style="western"><surname>Dorahy</surname>, <given-names>M. J.</given-names></string-name>, <string-name name-style="western"><surname>Loewenstein</surname>, <given-names>R. J.</given-names></string-name>, <string-name name-style="western"><surname>Cardena</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Carde&#241;a</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Frewen</surname>, <given-names>P. A.</given-names></string-name>, <string-name name-style="western"><surname>Carlson</surname>, <given-names>E. B.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Spiegel</surname>, <given-names>D.</given-names></string-name></person-group> (<year>2012</year>). <article-title>Evaluation of the evidence for the trauma and fantasy models of dissociation</article-title>. <source><italic toggle="yes">Psychological Bulletin</italic></source>, <volume><italic toggle="yes">138</italic></volume>(<issue>3</issue>), <fpage>550</fpage>&#8211;<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1037/a0027447</pub-id><pub-id pub-id-type="pmid">22409505</pub-id></mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dimitrova</surname>, <given-names>L. I.</given-names></string-name>, <string-name name-style="western"><surname>Lawrence</surname>, <given-names>A. J.</given-names></string-name>, <string-name name-style="western"><surname>Vissia</surname>, <given-names>E. M.</given-names></string-name>, <string-name name-style="western"><surname>Chalavi</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Kakouris</surname>, <given-names>A. F.</given-names></string-name>, <string-name name-style="western"><surname>Veltman</surname>, <given-names>D. J.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Reinders</surname>, <given-names>A. A. T. S.</given-names></string-name></person-group> (<year>2024</year>). <article-title>Inter-identity amnesia in dissociative identity disorder resolved: A behavioural and neurobiological study</article-title>. <source><italic toggle="yes">Journal of Psychiatric Research</italic></source>, <volume><italic toggle="yes">174</italic></volume>, <fpage>220</fpage>&#8211;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2024.04.026</pub-id><pub-id pub-id-type="pmid">38653030</pub-id></mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gantt</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Tinnin</surname>, <given-names>L. W.</given-names></string-name></person-group> (<year>2007</year>). <article-title>Intensive trauma therapy of PTSD and dissociation: An outcome study</article-title>. <source><italic toggle="yes">The Arts in Psychotherapy</italic></source>, <volume><italic toggle="yes">34</italic></volume>(<issue>1</issue>), <fpage>69</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.aip.2006.09.007</pub-id></mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gold</surname>, <given-names>S. N.</given-names></string-name>, <string-name name-style="western"><surname>Elhai</surname>, <given-names>J. D.</given-names></string-name>, <string-name name-style="western"><surname>Rea</surname>, <given-names>B. D.</given-names></string-name>, <string-name name-style="western"><surname>Weiss</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Masino</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western"><surname>Morris</surname>, <given-names>S. L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>McIninch</surname>, <given-names>J.</given-names></string-name></person-group> (<year>2001</year>). <article-title>Contextual treatment of dissociative identity disorder</article-title>. <source><italic toggle="yes">Journal of Trauma &amp; Dissociation</italic></source>, <volume><italic toggle="yes">2</italic></volume>(<issue>4</issue>), <fpage>5</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1300/J229v02n04_02</pub-id><pub-id pub-id-type="pmid">29389293</pub-id></mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Humphreys</surname>, <given-names>C. L.</given-names></string-name>, <string-name name-style="western"><surname>Rubin</surname>, <given-names>K. S.</given-names></string-name>, <string-name name-style="western"><surname>Knudson</surname>, <given-names>R. M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Stiles</surname>, <given-names>W. B.</given-names></string-name></person-group> (<year>2005</year>). <article-title>The assimilation of anger in a case of dissociative identity disorder</article-title>. <source><italic toggle="yes">Counselling Psychology Quarterly</italic></source>, <volume><italic toggle="yes">18</italic></volume>(<issue>2</issue>), <fpage>121</fpage>&#8211;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1080/09515070500136488</pub-id></mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>International Society for the Study of Trauma and Dissociation</collab></person-group>. (<year>2011</year>). <article-title>Guidelines for treating dissociative identity disorder in adults</article-title>. <source><italic toggle="yes">Journal of Trauma and Dissociation</italic></source>, <volume><italic toggle="yes">12</italic></volume>(<issue>2</issue>), <fpage>115</fpage>&#8211;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1080/15299732.2011.537247</pub-id><pub-id pub-id-type="pmid">21391103</pub-id></mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jepsen</surname>, <given-names>E. K. K.</given-names></string-name>, <string-name name-style="western"><surname>Langeland</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Sexton</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Heir</surname>, <given-names>T.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Inpatient treatment for early sexually abused adults: A naturalistic 12-month follow-up study</article-title>. <source><italic toggle="yes">Psychological Trauma: Theory, Research, Practice, and Policy</italic></source>, <volume><italic toggle="yes">6</italic></volume>(<issue>2</issue>), <fpage>142</fpage>&#8211;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1037/a0031646</pub-id></mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kellett</surname>, <given-names>S.</given-names></string-name></person-group> (<year>2005</year>). <article-title>The treatment of dissociative identity disorder with cognitive analytic therapy: Experimental evidence of sudden gains</article-title>. <source><italic toggle="yes">Journal of Trauma &amp; Dissociation</italic></source>, <volume><italic toggle="yes">6</italic></volume>(<issue>3</issue>), <fpage>55</fpage>&#8211;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1300/J229v06n03_03</pub-id><pub-id pub-id-type="pmid">16172082</pub-id></mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lanius</surname>, <given-names>R. A.</given-names></string-name></person-group> (<year>2015</year>). <article-title>Trauma-related dissociation and altered states of consciousness: A call for clinical, treatment, and neuroscience research</article-title>. <source><italic toggle="yes">European Journal of Psychotraumatology</italic></source>, <volume><italic toggle="yes">6</italic></volume>(<issue>1</issue>), Article 27905. <pub-id pub-id-type="doi">10.3402/ejpt.v6.27905</pub-id><pub-id pub-id-type="pmcid">PMC4439425</pub-id><pub-id pub-id-type="pmid">25994026</pub-id></mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lilienfeld</surname>, <given-names>S. O.</given-names></string-name></person-group> (<year>2007</year>). <article-title>Psychological treatments that cause harm</article-title>. <source><italic toggle="yes">Perspectives on Psychological Science</italic></source>, <volume><italic toggle="yes">2</italic></volume>(<issue>1</issue>), <fpage>53</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1111/j.1745-6916.2007.00029.x</pub-id><pub-id pub-id-type="pmid">26151919</pub-id></mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Loewenstein</surname>, <given-names>R. J.</given-names></string-name>, <string-name name-style="western"><surname>Lewis-Fernandez</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Frewen</surname>, <given-names>P.</given-names></string-name></person-group> (<year>2024</year>). <part-title>Dissociative disorders</part-title>. In <person-group person-group-type="editor"><string-name name-style="western"><given-names>R.</given-names><surname>Boland</surname></string-name> &amp; <string-name name-style="western"><given-names>M. L.</given-names><surname>Verduin</surname></string-name></person-group> (Eds.), <source><italic toggle="yes">Kaplan &amp; Sadock&#8217;s comprehensive textbook of psychiatry</italic></source> (Vol. 1, pp. <fpage>1927</fpage>&#8211;<lpage>2026</lpage>). <publisher-name>Wolters Kluwer</publisher-name>.</mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Manchester</surname>, <given-names>C. F.</given-names></string-name>, <string-name name-style="western"><surname>Allen</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Tachiki</surname>, <given-names>K. H.</given-names></string-name></person-group> (<year>1998</year>). <article-title>Treatment of dissociative identity disorder with neurotherapy and group self-exploration</article-title>. <source><italic toggle="yes">Journal of Neurotherapy</italic></source>, <volume><italic toggle="yes">2</italic></volume>(<issue>4</issue>), <fpage>40</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1300/J184v02n04_03</pub-id></mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McHugh</surname>, <given-names>M. L.</given-names></string-name></person-group> (<year>2012</year>). <article-title>Interrater reliability: The kappa statistic</article-title>. <source><italic toggle="yes">Biochemia Medica</italic></source>, <volume><italic toggle="yes">22</italic></volume>(<issue>3</issue>), <fpage>276</fpage>&#8211;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.11613/BM.2012.031</pub-id><pub-id pub-id-type="pmid">23092060</pub-id><pub-id pub-id-type="pmcid">PMC3900052</pub-id></mixed-citation></ref><ref id="CIT0030"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Methley</surname>, <given-names>A. M.</given-names></string-name>, <string-name name-style="western"><surname>Campbell</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Chew-Graham</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>McNally</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Cheraghi-Sohi</surname>, <given-names>S.</given-names></string-name></person-group> (<year>2014</year>). <article-title>PICO, PICOS, and SPIDER: A comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews</article-title>. <source><italic toggle="yes">BMC Health Services Research</italic></source>, <volume><italic toggle="yes">14</italic></volume>(<issue>1</issue>), <fpage>579</fpage>. <pub-id pub-id-type="doi">10.1186/s12913-014-0579-0</pub-id><pub-id pub-id-type="pmid">25413154</pub-id><pub-id pub-id-type="pmcid">PMC4310146</pub-id></mixed-citation></ref><ref id="CIT0031"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Moher</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Liberati</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Tetzlaff</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Altman</surname>, <given-names>D. G.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Group</surname>, <given-names>T. P.</given-names></string-name></person-group> (<year>2009</year>). <article-title>Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement</article-title>. <source><italic toggle="yes">PLoS Medicine</italic></source>, <volume><italic toggle="yes">6</italic></volume>(<issue>7</issue>), <fpage>e1000097</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id><pub-id pub-id-type="pmid">19621072</pub-id><pub-id pub-id-type="pmcid">PMC2707599</pub-id></mixed-citation></ref><ref id="CIT0032"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Myrick</surname>, <given-names>A. C.</given-names></string-name>, <string-name name-style="western"><surname>Brand</surname>, <given-names>B. L.</given-names></string-name>, <string-name name-style="western"><surname>McNary</surname>, <given-names>S. W.</given-names></string-name>, <string-name name-style="western"><surname>Classen</surname>, <given-names>C. C.</given-names></string-name>, <string-name name-style="western"><surname>Lanius</surname>, <given-names>R. A.</given-names></string-name>, <string-name name-style="western"><surname>Loewenstein</surname>, <given-names>R. L.</given-names></string-name>, <string-name name-style="western"><surname>Pain</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Putnam</surname>, <given-names>F. W.</given-names></string-name></person-group> (<year>2012</year>). <article-title>An exploration of young adults&#8217; progress in treatment for dissociative disorder</article-title>. <source><italic toggle="yes">Journal of Trauma &amp; Dissociation</italic></source>, <volume><italic toggle="yes">13</italic></volume>(<issue>5</issue>), <fpage>582</fpage>&#8211;<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1080/15299732.2012.694841</pub-id><pub-id pub-id-type="pmid">22989245</pub-id></mixed-citation></ref><ref id="CIT0033"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Myrick</surname>, <given-names>A. C.</given-names></string-name>, <string-name name-style="western"><surname>Webermann</surname>, <given-names>A. R.</given-names></string-name>, <string-name name-style="western"><surname>Langeland</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Putnam</surname>, <given-names>F. W.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Brand</surname>, <given-names>B. L.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Treatment of dissociative disorders and reported changes in inpatient and outpatient cost estimates</article-title>. <source><italic toggle="yes">European Journal of Psychotraumatology</italic></source>, <volume><italic toggle="yes">8</italic></volume>(<issue>1</issue>), Article 1375829. <pub-id pub-id-type="doi">10.1080/20008198.2017.1375829</pub-id><pub-id pub-id-type="pmcid">PMC5632785</pub-id><pub-id pub-id-type="pmid">29038681</pub-id></mixed-citation></ref><ref id="CIT0034"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Page</surname>, <given-names>M. J.</given-names></string-name>, <string-name name-style="western"><surname>McKenzie</surname>, <given-names>J. E.</given-names></string-name>, <string-name name-style="western"><surname>Bossuyt</surname>, <given-names>P. M.</given-names></string-name>, <string-name name-style="western"><surname>Boutron</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western"><surname>Hoffmann</surname>, <given-names>T. C.</given-names></string-name>, <string-name name-style="western"><surname>Mulrow</surname>, <given-names>C. D.</given-names></string-name>, <string-name name-style="western"><surname>Shamseer</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Tetzlaff</surname>, <given-names>J.M.</given-names></string-name>, <string-name name-style="western"><surname>Akl</surname>, <given-names>E.A.</given-names></string-name>, <string-name name-style="western"><surname>Brennan</surname>, <given-names>S.E.</given-names></string-name>, <string-name name-style="western"><surname>Chou</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Moher</surname>, <given-names>D.</given-names></string-name></person-group> (<year>2021</year>). <article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title>. <source><italic toggle="yes">BMJ (Clinical Research Ed.)</italic></source>, <volume><italic toggle="yes">373</italic></volume>, <fpage>71</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id><pub-id pub-id-type="pmid">33782057</pub-id></mixed-citation></ref><ref id="CIT0035"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pais</surname>, <given-names>S.</given-names></string-name></person-group> (<year>2009</year>). <article-title>A systemic approach to the treatment of dissociative identity disorder</article-title>. <source><italic toggle="yes">Journal of Family Psychotherapy</italic></source>, <volume><italic toggle="yes">20</italic></volume>(<issue>1</issue>), <fpage>72</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1080/08975350802716566</pub-id></mixed-citation></ref><ref id="CIT0036"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pollock</surname>, <given-names>B. E.</given-names></string-name>, <string-name name-style="western"><surname>Macfie</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Elledge</surname>, <given-names>L. C.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Evidence for phase-based psychotherapy as a treatment for dissociative identity disorder comorbid with major depressive disorder and alcohol dependence</article-title>. <source><italic toggle="yes">Journal of Trauma &amp; Dissociation</italic></source>, <volume><italic toggle="yes">18</italic></volume>(<issue>4</issue>), <fpage>595</fpage>&#8211;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1080/15299732.2016.1241853</pub-id><pub-id pub-id-type="pmid">27689689</pub-id></mixed-citation></ref><ref id="CIT0037"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Purcell</surname>, <given-names>J. B.</given-names></string-name>, <string-name name-style="western"><surname>Brand</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Browne</surname>, <given-names>H. A.</given-names></string-name>, <string-name name-style="western"><surname>Chefetz</surname>, <given-names>R. A.</given-names></string-name>, <string-name name-style="western"><surname>Shanahan</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Bair</surname>, <given-names>Z. A.</given-names></string-name>, <string-name name-style="western"><surname>Baranowski</surname>, <given-names>K. A.</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western"><surname>Mangones</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Modell</surname>, <given-names>R. L.</given-names></string-name>, <string-name name-style="western"><surname>Palermo</surname>, <given-names>C. A.</given-names></string-name>, <string-name name-style="western"><surname>Robertson</surname>, <given-names>E. C.</given-names></string-name>, <string-name name-style="western"><surname>Robinson</surname>, <given-names>M. A.</given-names></string-name>, <string-name name-style="western"><surname>Ward</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Winternitz</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Kaufman</surname>, <given-names>M. L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Lebois</surname>, <given-names>L. A. M.</given-names></string-name></person-group> (<year>2024</year>). <article-title>Treatment of dissociative identity disorder: Leveraging neurobiology to optimise success</article-title>. <source><italic toggle="yes">Expert Review of Neurotherapeutics</italic></source>, <volume><italic toggle="yes">24</italic></volume>(<issue>3</issue>), <fpage>273</fpage>&#8211;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1080/14737175.2024.2316153</pub-id><pub-id pub-id-type="pmid">38357897</pub-id><pub-id pub-id-type="pmcid">PMC10950423</pub-id></mixed-citation></ref><ref id="CIT0038"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rafiq</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Campodonico</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Varese</surname>, <given-names>F.</given-names></string-name></person-group> (<year>2018</year>). <article-title>The relationship between childhood adversities and dissociation in severe mental illness: A meta-analytic review</article-title>. <source><italic toggle="yes">Acta Psychiatrica Scandinavica</italic></source>, <volume><italic toggle="yes">138</italic></volume>(<issue>6</issue>), <fpage>509</fpage>&#8211;<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1111/acps.12969</pub-id><pub-id pub-id-type="pmid">30338524</pub-id></mixed-citation></ref><ref id="CIT0039"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Raison</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Andrea</surname>, <given-names>S.</given-names></string-name></person-group> (<year>2023</year>). <article-title>Childhood trauma in patients with dissociative identity disorder: A systematic review of data from 1990 to 2022</article-title>. <source><italic toggle="yes">European Journal of Trauma &amp; Dissociation</italic></source>, <volume><italic toggle="yes">7</italic></volume>(<issue>1</issue>), Article 100310. <pub-id pub-id-type="doi">10.1016/j.ejtd.2022.100310</pub-id></mixed-citation></ref><ref id="CIT0040"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Reinders</surname>, <given-names>A. A. T. S.</given-names></string-name>, <string-name name-style="western"><surname>Marquand</surname>, <given-names>A. F.</given-names></string-name>, <string-name name-style="western"><surname>Schlumpf</surname>, <given-names>Y. R.</given-names></string-name>, <string-name name-style="western"><surname>Chalavi</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Vissia</surname>, <given-names>E. M.</given-names></string-name>, <string-name name-style="western"><surname>Nijenhuis</surname>, <given-names>E. R. S.</given-names></string-name>, <string-name name-style="western"><surname>Dazzan</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>J&#228;ncke</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Veltman</surname>, <given-names>D. J.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Aiding the diagnosis of dissociative identity disorder: Pattern recognition study of brain biomarkers</article-title>. <source><italic toggle="yes">The British Journal of Psychiatry</italic></source>, <volume><italic toggle="yes">215</italic></volume>(<issue>3</issue>), <fpage>536</fpage>&#8211;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.2018.255</pub-id><pub-id pub-id-type="pmid">30523772</pub-id></mixed-citation></ref><ref id="CIT0041"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Reinders</surname>, <given-names>A. A. T. S.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Veltman</surname>, <given-names>D. J.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Dissociative identity disorder: Out of the shadows at last?</article-title><source><italic toggle="yes">The British Journal of Psychiatry</italic></source>, <volume><italic toggle="yes">219</italic></volume>(<issue>2</issue>), <fpage>413</fpage>&#8211;<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.2020.168</pub-id><pub-id pub-id-type="pmid">33023686</pub-id></mixed-citation></ref><ref id="CIT0042"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Reinders</surname>, <given-names>A. A. T. S.</given-names></string-name>, <string-name name-style="western"><surname>Young</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Veltman</surname>, <given-names>D. J.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Dissociative identity disorder: A pharmacological challenge?</article-title><source><italic toggle="yes">The British Journal of Psychiatry</italic></source>, <volume><italic toggle="yes">220</italic></volume>(<issue>2</issue>), <fpage>98</fpage>&#8211;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.2021.74</pub-id></mixed-citation></ref><ref id="CIT0043"><mixed-citation publication-type="journal"><person-group person-group-type="author" specific-use="dash"><string-name name-style="western"><surname>Reinders</surname>, <given-names>A. A. T. S.</given-names></string-name>, <string-name name-style="western"><surname>Young</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Veltman</surname>, <given-names>D. J.</given-names></string-name></person-group> (<year>2023</year>). <article-title>Biomarkers of dissociation</article-title>. <source><italic toggle="yes">BJPsych Open</italic></source>, <volume><italic toggle="yes">9</italic></volume>(<issue>4</issue>), <fpage>e119</fpage>. <pub-id pub-id-type="doi">10.1192/bjo.2023.511</pub-id><pub-id pub-id-type="pmid">37395122</pub-id><pub-id pub-id-type="pmcid">PMC10375900</pub-id></mixed-citation></ref><ref id="CIT0044"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ross</surname>, <given-names>C. A.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Haley</surname>, <given-names>C.</given-names></string-name></person-group> (<year>2004</year>). <article-title>Acute stabilization and three-month follow-up in a trauma program</article-title>. <source><italic toggle="yes">Journal of Trauma &amp; Dissociation</italic></source>, <volume><italic toggle="yes">5</italic></volume>(<issue>1</issue>), <fpage>103</fpage>&#8211;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1300/J229v05n01_06</pub-id></mixed-citation></ref><ref id="CIT0045"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Roydeva</surname>, <given-names>M. I.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Reinders</surname>, <given-names>A. A. T. S.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Biomarkers of pathological dissociation: A systematic review</article-title>. <source><italic toggle="yes">Neuroscience and Biobehavioural Reviews</italic></source>, <volume><italic toggle="yes">123</italic></volume>, <fpage>120</fpage>&#8211;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2020.11.019</pub-id><pub-id pub-id-type="pmid">33271160</pub-id></mixed-citation></ref><ref id="CIT0046"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sar</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western"><surname>Ozturk</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Kundakci</surname>, <given-names>T.</given-names></string-name></person-group> (<year>2002</year>). <article-title>Psychotherapy of an adolescent with dissociative identity disorder: Change in Rorschach patterns</article-title>. <source><italic toggle="yes">Journal of Trauma &amp; Dissociation</italic></source>, <volume><italic toggle="yes">3</italic></volume>(<issue>2</issue>), <fpage>81</fpage>&#8211;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1300/J229v03n02_05</pub-id></mixed-citation></ref><ref id="CIT0048"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Schiepek</surname>, <given-names>G. K.</given-names></string-name>, <string-name name-style="western"><surname>Stoger-Schmidinger</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Aichhorn</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Scholler</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Aas</surname>, <given-names>B.</given-names></string-name></person-group> (<year>2016</year>). <article-title>Systemic case formulation, individualised process monitoring, and state dynamics in a case of dissociative identity disorder</article-title>. <source><italic toggle="yes">Frontiers in Psychology</italic></source>, <volume><italic toggle="yes">7</italic></volume>, <fpage>1545</fpage>.<pub-id pub-id-type="pmid">27812338</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fpsyg.2016.01545</pub-id><pub-id pub-id-type="pmcid">PMC5072376</pub-id></mixed-citation></ref><ref id="CIT0049"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Spitzer</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Barnow</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Freyberger</surname>, <given-names>H. J.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Grabe</surname>, <given-names>H. J.</given-names></string-name></person-group> (<year>2007</year>). <article-title>Dissociation predicts symptom-related treatment outcome in short-term inpatient psychotherapy</article-title>. <source><italic toggle="yes">Australian and New Zealand Journal of Psychiatry</italic></source>, <volume><italic toggle="yes">41</italic></volume>(<issue>8</issue>), <fpage>682</fpage>&#8211;<lpage>687</lpage>. <pub-id pub-id-type="doi">10.1080/00048670701449146</pub-id><pub-id pub-id-type="pmid">17620165</pub-id></mixed-citation></ref><ref id="CIT0050"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Steele</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Van er Hart</surname>, <given-names>O.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Nijenhuis</surname>, <given-names>E. R.</given-names></string-name></person-group> (<year>2005</year>). <article-title>Phase-oriented treatment of structural dissociation in complex traumatisation: Overcoming trauma-related phobias</article-title>. <source><italic toggle="yes">Journal of Trauma &amp; Dissociation</italic></source>, <volume><italic toggle="yes">6</italic></volume>(<issue>3</issue>), <fpage>11</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1300/J229v06n03_02</pub-id><pub-id pub-id-type="pmid">16172081</pub-id></mixed-citation></ref><ref id="CIT0051"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Subramanyam</surname>, <given-names>A. A.</given-names></string-name>, <string-name name-style="western"><surname>Somaiya</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Shankar</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Nasirabadi</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Shah</surname>, <given-names>H. R.</given-names></string-name>, <string-name name-style="western"><surname>Paul</surname>, <given-names>I.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Ghildiyal</surname>, <given-names>R.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Psychological interventions for dissociative disorders</article-title>. <source><italic toggle="yes">Indian Journal of Psychiatry</italic></source>, <volume><italic toggle="yes">62</italic></volume>(<issue>2</issue>), <fpage>280</fpage>&#8211;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.4103/psychiatry.IndianJPsychiatry_777_19</pub-id><pub-id pub-id-type="pmcid">PMC7001344</pub-id><pub-id pub-id-type="pmid">32055070</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>